Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
KLK3	"APS, PSA"	ENSG00000142515	"Kallikrein related peptidase 3"	P07288	19	50854915-50860764	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	115	"prostate: 447.4"	"Group enriched"	"Detected in some"	135	"BEWO: 21.9;NB-4: 18.5;RPMI-8226: 12.2;SH-SY5Y: 7.3;U-2197: 7.5"	"Cancer enriched"	"Detected in some"	3905	"prostate cancer: 4241.6"	"Region enriched"	"Detected in single"	8	"cerebral cortex: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB000070, HPA000764"	Enhanced				"Secreted in male reproductive system"					"CAB000070: , HPA000764: AB_1079700"	"unprognostic (5.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.90e-2)"		"unprognostic (1.09e-2)"				"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.15e-1)"		0.1	0.3	0.0	0.1	0.0	0.0	0.7	0.0	1.0	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	447.4	0.0	0.1	3.8	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0
POTEH	"A26C3, ACTBL1, CT104.7, POTE22"	ENSG00000198062	"POTE ankyrin domain family member H"	Q6S545	22	15690026-15721631	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	62	"prostate: 9.5;testis: 2.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;U-2 OS: 4.7;U-266/84: 1.3"	"Cancer enriched"	"Detected in single"	28	"prostate cancer: 1.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (4.66e-2)"											"unprognostic (1.02e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		9.5	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
POTEM	"ACT, P704P, POTE14beta"	ENSG00000222036	"POTE ankyrin domain family member M"	A6NI47	14	18967434-18999012	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	31	"prostate: 4.0;testis: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																	"unprognostic (6.16e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		4.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KLK2		ENSG00000167751	"Kallikrein related peptidase 2"	P20151	19	50861568-50880567	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"prostate: 163.5"	"Cell line enhanced"	"Detected in many"		"NB-4: 9.9"	"Cancer enriched"	"Detected in some"	1666	"prostate cancer: 989.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA000764	Supported				"Secreted in male reproductive system"					"HPA000764: AB_1079700"	"unprognostic (3.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.53e-2)"		"unprognostic (1.15e-1)"		"unprognostic (8.97e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.04e-1)"	0.0	0.1	0.0	0.1	0.0	1.1	0.2	0.0	0.6	0.0	0.0	0.0	0.6	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	163.5	0.0	0.1	2.3	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.2	0.0	2.2	1.9	5.7	2.2	1.6	1.3	0.5	1.7	1.1	0.6	1.6	0.0	0.8	4.9	0.5	0.3	0.2	0.2	0.6	0.7	1.8	0.2	0.0	2.0	0.2	0.0	0.3	1.7	1.1	0.0	1.3	0.4	0.0	0.3	3.1	0.4	0.3	0.3	0.4	0.0	1.4	1.9	0.3	1.8	1.2	9.9	1.1	0.0	0.9	0.0	2.8	0.0	1.6	0.9	1.5	0.3	1.3	1.3	1.2	0.4	0.8	1.3	1.9	4.8	1.6	1.8	3.2	0.8	1.9	1.7	1.4	0.9	2.2	1.6	1.2	1.0	1.0	1.0	0.8	1.0	0.5	2.2	0.8	1.3	5.7	1.6	0.8	1.9	0.4	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
GPRC6A	bA86F4.3	ENSG00000173612	"G protein-coupled receptor class C group 6 member A"	Q5T6X5	6	116792085-116829037	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	21	"adrenal gland: 1.1;kidney: 3.2;prostate: 1.4;salivary gland: 3.6"	"Group enriched"	"Detected in some"	6	"U-266/70: 5.9;U-266/84: 1.7"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																"unprognostic (9.16e-2)"									"unprognostic (2.48e-1)"			"unprognostic (4.38e-3)"			0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.4	0.1		3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MSMB	"IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94"	ENSG00000263639	"Microseminoprotein beta"	P08118	10	46033307-46046269	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"prostate: 437.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 20.0;NB-4: 16.1;RPMI-8226: 8.4;SH-SY5Y: 4.6;SK-BR-3: 4.7;U-2197: 9.5"	"Cancer enriched"	"Detected in many"	42	"prostate cancer: 3435.3"					"Cell type enriched"	"Detected in single"	5	"eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"									"CAB026357, HPA051257"	Enhanced				"Secreted in male reproductive system"	3700000	3700000			"CAB026357: , HPA051257: AB_2681410"	"unprognostic (6.47e-2)"	"unprognostic (7.21e-3)"		"unprognostic (1.37e-2)"		"unprognostic (8.18e-3)"	"unprognostic (4.28e-3)"	"unprognostic (9.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"		"unprognostic (2.01e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (7.19e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	1.0	0.8	0.0	0.1	0.1	0.0	1.8	0.1	0.0	7.2	0.0	0.0		0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	437.8	0.0	0.0	14.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	26.8	0.6	0.0	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.2	16.1	0.2	0.0	0.0	0.0	8.4	0.0	1.2	0.9	4.6	0.0	4.7	0.0	0.3	0.0	0.0	0.0	0.0	9.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PLA2G4D	cPLA2delta	ENSG00000159337	"Phospholipase A2 group IVD"	Q86XP0	15	42067009-42094554	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 35.6;prostate: 22.4;skin 1: 13.9;tongue: 11.6;vagina: 17.1"	"Cell line enriched"	"Detected in single"	38	"RPMI-8226: 19.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (9.33e-3)"	"unprognostic (4.35e-2)"		"unprognostic (5.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.64e-7)"	"unprognostic (2.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.32e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	35.6	0.1	0.1	0.1	0.0	1.4	0.3	1.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	22.4	0.0	0.1	0.6	0.1	0.1	13.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	11.6	1.2	0.6	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PAGE4	"CT16.7, GAGEC1, PAGE-4"	ENSG00000101951	"PAGE family member 4"	O60829	X	49829260-49833973	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"epididymis: 129.2;placenta: 199.4;prostate: 58.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.8;U-266/70: 8.4;U-266/84: 30.7"	"Group enriched"	"Detected in some"	17	"liver cancer: 14.8;prostate cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA023880	Enhanced		Approved	"Golgi apparatus,Vesicles"				Vesicles	Vesicles	"HPA023880: AB_1854930"				"unprognostic (8.56e-2)"			"unprognostic (1.47e-1)"			"unprognostic (1.04e-1)"		"unprognostic (4.82e-3)"			"unprognostic (5.37e-2)"			0.2	0.7	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.6	0.1	0.2	5.7	0.0	6.6	129.2	0.1	6.8	0.1	0.1	0.4	0.5	0.8	0.1	0.2	0.1	0.1	0.2	0.9	0.1	0.0	0.6	199.4	0.2	58.4	0.0	0.1	0.1	9.8	0.8	0.1	0.1	2.4	0.2	0.1	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.2	0.2	0.4	0.5	0.1	0.2	0.2	0.1
CFC1	"CRYPTIC, HTX2"	ENSG00000136698	"Cripto, FRL-1, cryptic family 1"	P0CG37	2	130592168-130599575	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"brain: 13.0;pancreas: 21.9;pituitary gland: 22.4;prostate: 7.6;stomach 1: 9.4"	"Group enriched"	"Detected in some"	21	"RPMI-8226: 19.1;SCLC-21H: 10.9"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 4.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041773	Uncertain				"Secreted - unknown location"					"HPA041773: AB_2677664"					"unprognostic (6.65e-2)"						"unprognostic (2.19e-3)"	"unprognostic (1.11e-3)"			"unprognostic (2.01e-1)"			0.1	0.1	0.9	0.0	2.1	0.0	0.0	2.3	1.1	0.1	0.5			0.1	0.1	0.1	0.0	1.2	0.1	0.3	0.2	13.0	0.1	0.0	0.0	0.0	2.5		0.1	21.9	0.0	22.4	0.0		7.6	0.3		0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	9.4	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1										
RLN1	H1	ENSG00000107018	"Relaxin 1"	P04808	9	5334969-5339873	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"prostate: 25.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;HEL: 4.7;SK-BR-3: 1.0"	"Cancer enriched"	"Detected in some"	106	"prostate cancer: 67.0"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.1"	"Cell type enhanced"	"Detected in single"		"gdTCR: 1.6"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.6"														"Secreted to blood"						"unprognostic (7.12e-6)"	"unprognostic (2.32e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.04e-1)"		"unprognostic (4.32e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.08e-4)"	"unprognostic (8.15e-2)"	"unprognostic (2.89e-4)"	"unprognostic (8.82e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.53e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.1	0.9	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	2.1	0.0	0.0	0.0	0.0	0.0
LMAN1L	"ERGIC-53L, ERGL"	ENSG00000140506	"Lectin, mannose binding 1 like"	Q9HAT1	15	74812716-74825758	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"brain: 45.5;heart muscle: 18.0;lymphoid tissue: 13.5;prostate: 37.0;salivary gland: 17.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;Daudi: 3.7;HEK 293: 2.3;SCLC-21H: 2.4;SK-BR-3: 2.4"	"Cancer enriched"	"Detected in single"	45	"prostate cancer: 2.2"	"Region enriched"	"Detected in some"	22	"cerebellum: 45.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (4.51e-1)"							"unprognostic (2.44e-1)"		"unprognostic (4.26e-2)"	"unprognostic (3.09e-1)"			0.1	1.1	0.2	4.8	0.2	0.0	0.1	45.5	0.9	0.3	0.1	0.1	0.1	0.0	0.1	0.3	0.4	0.0	0.5	18.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	2.0	37.0	0.0	0.1	17.3	0.1	0.1	0.0	0.2	0.1	0.3	13.5	2.5	0.7	0.1	0.1	0.1	0.3	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.4	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.1	0.8	0.3	0.0	1.1	0.0	0.5	2.4	0.1	0.0	2.4	0.2	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.6	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	45.5	0.9	0.1	0.0	0.1	0.3	2.0	0.1
NEFH		ENSG00000100285	"Neurofilament heavy"	P12036	22	29480230-29491390	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 87.6;prostate: 116.0"	"Cell line enriched"	"Detected in some"	5	"SiHa: 61.9"	"Group enriched"	"Detected in many"	7	"prostate cancer: 130.0;testis cancer: 31.8"	"Region enhanced"	"Detected in many"		"pons and medulla: 87.6"	"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007786, HPA061615"	Enhanced									"CAB007786: AB_598179, HPA061615: AB_2684568"	"prognostic favourable (2.33e-6)"	"unprognostic (6.17e-3)"	"unprognostic (9.74e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.85e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.47e-1)"	1.0	8.4	3.3	1.4	5.4	1.0	1.4	7.1	31.6	0.9	0.9	2.2	0.0	0.9	1.0	1.1	0.8	0.8	0.9	0.8	8.3	17.1	1.2	0.9	0.9	1.1	34.8	2.3	10.0	0.8	0.8	3.9	1.0	87.6	116.0	1.0	4.0	1.1	1.0	0.8	0.8	1.0	1.2	17.9	1.2	0.8	3.6	0.1	0.0	0.8	0.0	1.2	0.8	0.0	0.2	1.1	0.0	7.4	0.4	1.6	1.2	0.0	0.0	0.8	0.2	0.0	0.1	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	2.9	11.7	0.0	8.6	0.0	0.5	0.0	3.6	1.2	0.0	0.1	0.0	0.4	9.1	0.0	4.0	0.0	3.9	0.4	6.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	6.8	61.9	0.0	0.0	0.0	3.3	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.8	4.8	1.6	0.2	0.9	0.7	1.1	0.1	0.3	1.0	0.0	0.4	7.4	0.3	0.4	1.2	3.3	5.4	7.1	31.6	8.3	17.1	34.8	2.3	87.6	0.1
CHRNA2		ENSG00000120903	"Cholinergic receptor nicotinic alpha 2 subunit"	Q15822	8	27459761-27479883	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"brain: 11.6;prostate: 33.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;SiHa: 1.9;U-2197: 1.8;U-266/84: 1.2"	"Cancer enriched"	"Detected in single"	421	"prostate cancer: 30.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.8;plasmacytoid DC: 1.0"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.0;granulocytes: 1.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"			"unprognostic (2.23e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.19e-2)"	"unprognostic (6.29e-3)"			"unprognostic (1.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.47e-1)"		0.3	0.8	1.2	0.6	2.0	1.2	2.1	2.0	11.6	0.3	0.3	11.3	0.0	0.6	0.3	1.4	0.3	0.4	0.4	0.4	1.6	2.9	0.3	0.4	0.6	0.4	1.6	0.6	0.3	0.6	0.4	0.5	0.3	7.0	33.5	0.3	2.4	0.3	0.4	0.4	0.5	0.6	0.3	0.8	0.4	0.4	0.4	1.0	2.4	0.4	0.0	0.4	0.4	0.1	0.0	1.0	1.8	0.0	0.0	0.1	1.8	0.0	0.0	0.1	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.6	0.5	1.9	0.7	0.0	0.0	0.0	0.0	0.5	0.7	1.8	0.2	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.0	1.8	1.2	2.0	2.0	11.6	1.6	2.9	1.6	0.6	7.0	1.0
KLK4	"EMSP, EMSP1, KLK-L1, PRSS17, PSTS"	ENSG00000167749	"Kallikrein related peptidase 4"	Q9Y5K2	19	50906352-50910738	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"prostate: 79.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.2;HaCaT: 10.1;SK-BR-3: 6.5"	"Cancer enriched"	"Detected in many"	55	"prostate cancer: 463.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051839	Enhanced				"Secreted in male reproductive system"					"HPA051839: AB_2681632"	"unprognostic (3.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.66e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-3)"	"unprognostic (3.27e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.34e-1)"	0.2	0.8	0.1	0.3	0.1	0.1	0.7	0.2	0.5	2.0	1.2	0.0	3.8	1.8	1.5	7.7	0.4	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.5	79.3	0.8	0.2	3.2	2.1	0.7	2.4	1.2	0.6	0.1	0.1	0.3	0.6	0.1	0.0	8.7	0.0	0.0	0.2	0.2	0.1	0.4	0.6	0.1	0.0	0.3	0.0	5.0	2.1	0.2	0.3	0.0	0.0	4.5	0.1	0.0	0.0	0.0	4.6	8.2	0.5	0.4	0.1	10.1	0.0	5.4	0.0	1.3	1.4	1.6	3.7	1.7	0.0	1.7	2.3	0.0	2.6	0.0	0.0	0.0	0.9	4.2	0.0	1.2	0.1	2.5	0.1	0.4	0.3	0.5	1.1	0.0	3.3	0.0	0.6	0.3	6.5	0.0	5.2	0.4	1.1	0.3	0.3	1.3	0.3	2.6	1.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.5	0.3	0.2	0.2	0.0	0.5	0.1
POTEG	"A26C2, CT104.4, POTE-14, POTE14, POTE14alpha"	ENSG00000187537	"POTE ankyrin domain family member G"	Q6S5H5	14	19402486-19434341	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"blood: 14.0;prostate: 7.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;U-2 OS: 2.8"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.5"					"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (4.01e-1)"				"unprognostic (1.51e-1)"	"unprognostic (6.00e-2)"		"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.69e-2)"		"unprognostic (1.05e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"		"unprognostic (2.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		7.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1			0.0		0.0	0.1	0.1	2.9	10.2	14.0	10.7	3.7	6.8	12.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.8	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.2	6.4	14.0	4.8	10.7	3.7	2.9	4.3	4.5	10.2	2.9	3.4	5.2	7.6	3.7	10.3	2.8	6.8	12.2										
TRPM8		ENSG00000144481	"Transient receptor potential cation channel subfamily M member 8"	Q7Z2W7	2	233917398-234019522	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"liver: 16.7;prostate: 44.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 7.1;RPTEC TERT1: 10.6;SK-MEL-30: 10.6;WM-115: 6.4"	"Cancer enriched"	"Detected in some"	27	"prostate cancer: 72.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 3.0"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Low region specificity"	"Detected in many"														"unprognostic (4.41e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.60e-3)"	"prognostic favourable (7.15e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.88e-3)"	"unprognostic (7.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.36e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.53e-2)"	3.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	44.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.2	3.0	0.3	0.0	0.0	0.7	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.7	10.6	0.0	0.7	0.4	0.0	0.1	10.6	0.4	0.7	0.0	0.0	0.1	0.3	0.0	1.5	2.4	0.0	0.9	0.0	6.4	0.5	0.2	0.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.4	0.3	0.3	0.9	3.0	0.1	0.2	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.9
ACPP	"ACP-3, ACP3, PAP"	ENSG00000014257	"Acid phosphatase, prostate"	P15309	3	132317367-132368298	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"prostate: 345.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.2;NB-4: 7.7;RPMI-8226: 32.3;U-698: 9.4;U-87 MG: 9.0"	"Cancer enriched"	"Detected in many"	275	"prostate cancer: 1227.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 43.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"	9200	9200			"CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152"	"unprognostic (6.67e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.71e-1)"	0.4	0.6	0.4	0.7	1.6	1.4	0.8	0.3	0.7	3.9	0.4	0.2	0.0	0.4	0.3	2.5	14.7	0.6	0.2	0.9	0.3	0.3	6.2	0.3	2.0	2.7	0.6	0.8	0.4	0.8	0.5	0.3	5.3	0.7	345.2	0.7	0.8	9.1	0.2	0.3	2.5	0.4	0.4	2.2	1.0	0.5	1.0	0.6	0.2	1.3	6.6	6.8	0.5	1.5	0.2	11.2	43.1	9.7	0.9	0.0	2.9	0.2	0.0	0.0	0.0	0.1	0.6	7.0	0.1	10.2	0.0	0.0	0.2	0.2	5.7	0.4	0.0	2.9	0.0	0.0	0.0	0.0	0.3	1.1	0.2	0.1	0.1	4.1	0.1	0.6	0.8	0.0	0.0	0.0	0.1	1.6	0.1	0.1	0.0	7.7	0.4	1.2	0.0	0.0	32.3	3.1	3.8	0.0	2.5	0.0	1.2	0.3	0.2	3.7	0.0	0.0	0.1	1.5	0.0	0.4	0.2	9.4	9.0	7.3	0.1	0.0	9.7	43.1	0.0	8.6	0.0	0.2	0.0	0.0	11.2	0.0	0.0	0.0	8.5	0.9	7.7	0.8	0.0	2.9	0.4	1.6	0.3	0.7	0.3	0.3	0.6	0.8	0.7	0.6
CHRM1		ENSG00000168539	"Cholinergic receptor muscarinic 1"	P11229	11	62908679-62921807	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.7;prostate: 28.2;salivary gland: 25.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 8.0;SK-BR-3: 4.0;T-47d: 2.6;WM-115: 1.4"	"Cancer enriched"	"Detected in some"	16	"prostate cancer: 27.9"	"Group enriched"	"Detected in many"	10	"amygdala: 13.2;basal ganglia: 22.0;cerebral cortex: 34.7;hippocampal formation: 14.2;olfactory region: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"amygdala: 74.1;basal ganglia: 65.6;cerebral cortex: 83.5;hippocampal formation: 100.4;olfactory region: 36.8"					"HPA014101, CAB022366"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB022366: , HPA014101: AB_1854210"	"unprognostic (3.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.16e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.57e-4)"	"unprognostic (4.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.75e-1)"		0.5	3.7	13.2	0.8	22.0	0.5	3.2	0.2	34.7	0.6	1.3	0.5	0.0	1.0	0.7	0.6	0.8	0.8	0.7	0.6	14.2	1.7	0.7	0.6	2.9	0.6	1.4	14.0	0.5	1.2	1.0	0.1	0.8	0.1	28.2	1.3	1.3	25.3	0.6	0.6	2.6	1.3	0.6	0.3	0.6	1.9	0.6	1.8	0.0	0.8	0.0	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.0	0.7	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	22.0	0.2	34.7	14.2	1.7	1.4	14.0	0.1	1.8
HOXB13		ENSG00000159184	"Homeobox B13"	Q92826	17	48724763-48729178	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 18.6;prostate: 38.3"	"Cell line enriched"	"Detected in some"	13	"PC-3: 57.6"	"Cancer enriched"	"Detected in many"	17	"prostate cancer: 187.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004438, HPA062852, HPA065019"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB004438: AB_627744, HPA062852: AB_2684880, HPA065019: AB_2685406"	"unprognostic (4.81e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.73e-11)"	"unprognostic (1.39e-2)"	"unprognostic (4.50e-2)"		"unprognostic (1.12e-1)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	2.4	10.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.4	0.1	38.3	18.6	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	3.6	2.4	0.1	0.2	1.3	0.1	0.1	0.1	0.0	0.6	2.0	0.0	4.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.8	1.0	0.0	1.0	0.0	0.0	2.9	0.0	0.0	0.3	1.4	0.9	0.6	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.0	57.6	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.9	0.0	1.4	0.0	0.2	0.0	0.2	1.7	1.7	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
POTEI	POTE2beta	ENSG00000196834	"POTE ankyrin domain family member I"	P0CG38	2	130459455-130509666	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 6.5;prostate: 14.8;testis: 7.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.2;BEWO: 5.2;K-562: 5.0;U-2 OS: 11.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041264, HPA041271, HPA043260"	Uncertain									"HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396"	"unprognostic (2.52e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.62e-1)"		"unprognostic (3.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.38e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.4	0.2		14.8	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	7.0			0.1		0.0	0.0	0.0	1.6	4.6	6.0	4.9	1.8	3.2	6.5	0.7	0.7	0.3	4.2	0.0	0.0	5.2	0.2	0.0	0.0	0.0	2.2	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.7	2.2	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	5.0	0.9	0.0	2.6	0.2	0.3	0.5	0.3	0.0	0.1	2.1	0.0	0.1	0.2	0.8	0.1	2.3	0.0	1.7	0.0	0.2	0.1	11.3	0.4	0.0	2.6	1.5	0.1	0.2	0.1	0.1	3.0	3.0	6.0	2.4	4.8	1.9	1.6	2.0	2.3	4.6	1.3	1.6	2.4	4.0	1.8	4.9	1.6	3.2	6.5										
RFPL2	RNF79	ENSG00000128253	"Ret finger protein like 2"	O75678	22	32190435-32203477	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"brain: 7.9;prostate: 10.8"	"Cell line enhanced"	"Detected in some"		"A549: 2.4;REH: 1.0;SCLC-21H: 1.8;SK-MEL-30: 1.2"	"Cancer enriched"	"Detected in single"	15	"prostate cancer: 5.6"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"HPA046608, HPA048320, HPA072380"	Approved		Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Nuclear speckles"	"HPA046608: , HPA048320: AB_2680356, HPA072380: AB_2686515"	"unprognostic (3.81e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.29e-2)"	"unprognostic (9.66e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.64e-3)"	"prognostic favourable (4.16e-4)"	"unprognostic (2.04e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.62e-7)"	"unprognostic (3.50e-2)"	0.1	0.3	2.3	0.2	3.9	1.1	0.1	2.7	7.9	0.1	0.1			0.2	0.1	0.1	0.3	0.1	0.1	0.1	3.1	5.6	0.2	0.5	0.1	0.4	1.9		0.1	0.1	0.1	0.0	0.1		10.8	0.1		0.1	0.1	0.1	0.4	0.2	0.1	0.4	0.2	0.2	0.2			0.2		0.1	0.1	0.0	0.0	0.5	0.0	0.8	0.0	1.2	0.2	0.0	2.4	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.2	1.8	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	0.8	0.0	1.2	1.2	0.5	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2										
NPY	PYY4	ENSG00000122585	"Neuropeptide Y"	P01303	7	24284163-24291865	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 50.5;brain: 63.6;prostate: 131.2"	"Cell line enriched"	"Detected in some"	36	"SH-SY5Y: 121.1"	"Cancer enriched"	"Detected in many"	187	"prostate cancer: 1214.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016733, CAB034368, HPA036636, HPA044572, HPA056798"	Supported	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"	"Golgi apparatus"	"CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: , HPA056798: AB_2630371"			"unprognostic (2.00e-1)"	"prognostic unfavourable (5.78e-4)"	"unprognostic (4.15e-1)"					"unprognostic (3.76e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.52e-1)"		1.6	50.5	27.2	5.5	63.6	2.8	1.0	0.1	55.9	1.0	1.8	2.8	1.4	4.7	1.1	1.1	2.5	1.0	1.4	1.0	11.9	20.6	1.1	1.0	1.1	1.0	2.6	18.3	1.0	4.0	1.0	0.5	1.0	1.9	131.2	1.7	0.0	1.0	14.7	1.0	1.0	5.0	1.4	1.4	1.0	1.7	1.3	13.9	0.0	1.1	0.0	1.0	3.9	4.5	0.5	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	3.4	0.0	0.1	0.0	0.0	0.1	121.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	27.2	63.6	0.1	31.2	11.9	20.6	2.6	18.3	1.9	13.9
PABPC1L2B	RBM32B	ENSG00000184388	"Poly(A) binding protein cytoplasmic 1 like 2B"	Q5JQF8	X	73003517-73005713	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 12.2;prostate: 6.6"	"Group enriched"	"Detected in some"	30	"HAP1: 2.7;NTERA-2: 5.6;U-2 OS: 1.8"	"Cancer enriched"	"Detected in single"	23	"prostate cancer: 2.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041573	Approved									"HPA041573: AB_2677556"					"unprognostic (1.73e-1)"							"unprognostic (2.26e-1)"			"unprognostic (3.31e-1)"			0.1	1.6	3.3	0.1	4.9	0.1	0.1	6.4	12.2	0.1	0.1			0.4	0.1	0.5	0.1	0.1	0.1	0.1	3.5	10.2	0.1	0.1	0.1	0.1	3.3		0.1	0.1	0.1	1.0	0.1		6.6	0.1		0.8	0.5	0.1	0.1	0.1	0.1	2.1	0.2	0.1	1.5			0.1		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SERPINB11	EPIPIN	ENSG00000206072	"Serpin family B member 11 (gene/pseudogene)"	Q96P15	18	63647579-63726432	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 19.5;lymphoid tissue: 19.1;prostate: 23.7;tongue: 32.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.2;BEWO: 2.0;hTCEpi: 1.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"															"unprognostic (5.04e-3)"				"unprognostic (4.76e-2)"		"unprognostic (4.05e-2)"				"unprognostic (3.44e-1)"					"unprognostic (2.62e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0		0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	23.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	19.1	2.0	2.4	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0										
UPK2	"MGC138598, UP2, UPII"	ENSG00000110375	"Uroplakin 2"	O00526	11	118925164-118958559	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"prostate: 39.0;urinary bladder: 52.4;vagina: 25.9"	"Group enriched"	"Detected in some"	6	"MCF7: 45.9;RT4: 51.8"	"Cancer enriched"	"Detected in many"	72	"urothelial cancer: 339.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0;T-reg: 1.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043312, HPA061106"	Enhanced									"HPA043312: AB_2678420, HPA061106: AB_2684429"	"unprognostic (6.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.12e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.35e-3)"	"prognostic unfavourable (7.30e-7)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.00e-1)"	1.0	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.2	0.2	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	3.8	0.0	39.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	6.8	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.2	1.3	52.4	25.9	0.7	0.6	0.0	0.1	2.0	1.9	0.2	1.2	0.1	0.0	0.1	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.8	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.6	1.9	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0
DEFB136	DEFB137	ENSG00000205884	"Defensin beta 136"	Q30KP8	8	11973937-11974599	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"epididymis: 5.8;prostate: 1.5"	"Group enriched"	"Detected in some"	16	"HAP1: 2.7;WM-115: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA068255	Enhanced				"Secreted in male reproductive system"					"HPA068255: AB_2732780"																		0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0			0.0	0.3	5.8	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.3	0.0		1.5	0.0		0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3			0.0		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
POTEE	"A26C1, A26C1A, CT104.2, POTE-2, POTE2, POTE2gamma"	ENSG00000188219	"POTE ankyrin domain family member E"	Q6S8J3	2	131218067-131265278	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 2.4;prostate: 2.0;testis: 4.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.7;BEWO: 3.5;K-562: 3.6;U-2 OS: 6.8;U-266/84: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041264, HPA041271, HPA043260"	Uncertain									"HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396"	"unprognostic (3.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.59e-3)"		"unprognostic (3.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.61e-3)"	"unprognostic (5.77e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.6		2.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9			0.0		0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	2.4	0.1	0.0	0.2	2.7	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.1	0.7	2.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4										
PRAC1	"C17orf92, PRAC"	ENSG00000159182	"PRAC1 small nuclear protein"	Q96KF2	17	48721719-48722522	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"intestine: 62.1;prostate: 40.3"	"Cell line enriched"	"Detected in some"	33	"PC-3: 90.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 291.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"											HPA047871	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA047871: AB_2680195"			"unprognostic (7.59e-2)"									"unprognostic (2.43e-2)"			"unprognostic (2.04e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.6	2.0	30.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	40.3	62.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	9.9	5.1	0.8	0.0	2.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	90.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.5	0.0	0.2	0.5	0.0	0.4	0.0	0.8	0.1	0.1	2.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1
SLC45A3	"IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein"	ENSG00000158715	"Solute carrier family 45 member 3"	Q96JT2	1	205657851-205680459	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"prostate: 115.0"	"Cell line enriched"	"Detected in some"	30	"HMC-1: 138.2"	"Cancer enriched"	"Detected in all"	49	"prostate cancer: 539.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	226	"basophil: 22.6"	"Lineage enriched"	"Detected in single"	226	"granulocytes: 22.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA019073, HPA019075"	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA019073: AB_1857177, HPA019075: AB_1857179"	"unprognostic (1.80e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (4.04e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"prognostic favourable (7.33e-5)"	0.8	1.5	2.5	1.5	6.2	0.7	0.8	0.4	5.8	1.9	2.1	19.0	0.0	2.1	0.9	0.6	0.9	1.1	1.8	0.7	4.2	2.0	1.1	4.0	1.7	1.6	13.2	1.6	1.0	0.7	0.5	1.9	0.6	7.2	115.0	1.6	0.2	0.9	0.7	2.2	0.9	2.1	0.8	12.4	5.0	6.4	1.4	11.1	0.0	0.5	0.7	0.7	1.5	0.4	0.0	0.0	22.6	0.0	0.0	0.0	0.2	1.5	0.4	0.4	0.4	0.0	0.0	0.3	0.2	0.0	0.5	0.4	1.1	2.9	0.4	0.7	0.0	0.5	0.2	0.5	0.0	0.6	0.4	4.6	0.1	0.3	0.3	0.7	138.2	0.0	0.1	0.3	0.0	1.5	0.7	0.2	0.2	0.3	0.1	1.3	2.0	1.7	0.1	0.6	0.2	0.6	2.1	0.2	0.4	0.2	3.4	0.6	0.7	0.2	1.5	0.2	1.5	0.5	1.1	0.0	0.1	0.0	0.3	0.2	1.1	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	6.2	0.4	5.8	4.2	2.0	13.2	1.6	7.2	11.1
STEAP2	"IPCA-1, PCANAP1, STAMP1, STMP"	ENSG00000157214	"STEAP2 metalloreductase"	Q8NFT2	7	90167590-90238137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"prostate: 100.2"	"Cell line enhanced"	"Detected in many"		"A549: 13.2;CAPAN-2: 28.4;U-138 MG: 16.5"	"Cancer enriched"	"Detected in many"	12	"prostate cancer: 88.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029115, HPA055603"	Uncertain		Supported	Vesicles				Vesicles	Vesicles	"HPA029115: AB_10603894, HPA055603: "	"unprognostic (6.26e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.67e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.73e-2)"	"unprognostic (6.11e-2)"	"unprognostic (9.86e-5)"	"unprognostic (3.69e-2)"	10.7	4.1	6.2	9.7	14.5	1.3	13.6	8.7	18.2	7.0	8.3	2.3	2.2	5.7	5.4	3.6	9.1	7.5	8.8	9.4	5.1	5.2	6.5	3.6	10.8	1.6	3.2	11.1	19.5	6.4	10.3	17.6	1.4	6.0	100.2	7.0	3.8	6.8	6.7	2.3	3.5	5.9	9.0	2.9	3.0	9.2	2.3	1.6	1.6	5.8	1.2	2.5	10.4	19.9	1.1	0.4	1.3	0.4	0.3	0.2	0.0	1.8	13.2	0.3	3.7	7.1	6.9	0.2	1.6	3.4	0.2	0.5	2.4	28.4	0.0	0.2	4.4	1.1	2.9	2.0	0.5	0.0	2.8	0.0	0.0	0.6	0.6	0.0	0.0	5.0	0.4	6.9	1.4	3.6	0.0	0.2	3.9	0.0	0.0	0.4	5.4	1.4	0.0	0.0	0.1	6.2	3.9	0.3	1.3	2.0	0.0	0.0	10.0	0.0	3.0	16.5	3.7	2.3	1.4	0.0	0.0	0.0	7.1	0.0	0.6	1.3	0.4	0.5	0.2	0.2	0.1	1.1	0.1	0.1	0.0	0.4	0.2	0.2	1.2	0.3	0.2	0.4	0.0	0.0	6.2	14.5	8.7	18.2	5.1	5.2	3.2	11.1	6.0	1.6
TBX4		ENSG00000121075	"T-box 4"	P57082	17	61452404-61485110	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"lung: 31.1;placenta: 17.0;prostate: 15.0;smooth muscle: 26.0;urinary bladder: 18.6"	"Cell line enhanced"	"Detected in some"		"BJ: 5.3;Hep G2: 2.1;THP-1: 10.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 1.6"	"CAB032413, HPA044457"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"CAB032413: AB_2200705, HPA044457: AB_2678948"	"unprognostic (1.03e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-8)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.39e-2)"	0.5	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.0	0.6	15.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	26.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	18.6	4.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	0.1	0.0	0.0	5.3	0.5	0.4	0.4	1.9	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.8	0.0	0.0	2.1	0.5	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.5	0.0	10.5	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
NKX3-1	"BAPX2, NKX3.1, NKX3A"	ENSG00000167034	"NK3 homeobox 1"	Q99801	8	23678693-23682927	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"prostate: 95.3"	"Cell line enhanced"	"Detected in many"		"SiHa: 17.5;U-138 MG: 17.8;U-251 MG: 15.2"	"Cancer enriched"	"Detected in many"	65	"prostate cancer: 392.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"eosinophil: 23.5;neutrophil: 23.4"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 23.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025693, HPA078571"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA025693: , HPA078571: AB_2732384"	"unprognostic (1.47e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.56e-6)"	"unprognostic (6.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.69e-1)"	0.6	1.3	0.3	0.6	0.9	0.6	1.5	0.1	0.8	1.1	0.6	0.2	0.5	0.5	0.7	0.5	1.2	0.7	0.8	2.4	0.8	0.3	0.4	1.6	0.8	0.7	0.6	0.2	1.6	0.6	0.5	0.4	0.3	1.2	95.3	0.2	0.5	17.9	0.7	2.0	0.2	0.4	0.7	0.6	0.3	0.5	12.3	0.7	0.0	0.6	3.2	20.5	0.7	2.5	1.0	0.0	23.5	0.0	0.2	1.2	0.1	3.2	2.4	0.0	5.9	2.2	0.5	4.9	4.4	2.8	9.5	11.2	1.4	3.7	0.0	0.6	3.3	0.8	2.3	5.1	7.5	0.0	1.2	2.2	1.8	3.5	4.2	0.0	0.8	0.8	1.3	9.6	0.5	0.5	0.1	0.0	3.7	1.0	7.6	0.6	1.4	1.7	0.0	3.8	0.3	0.5	3.8	1.1	0.3	17.5	3.3	0.3	2.3	0.3	0.6	17.8	6.3	1.3	15.2	0.0	0.0	0.0	8.7	1.7	2.1	3.4	0.0	23.5	0.5	0.0	0.1	1.0	0.2	0.5	0.0	0.9	0.7	1.2	23.4	0.2	0.0	0.0	0.0	0.1	0.3	0.9	0.1	0.8	0.8	0.3	0.6	0.2	1.2	0.7
PRAC2	"C17orf93, HOXB-AS5, HOXB13-AS1, NCRNA00253"	ENSG00000229637	"Prostate cancer susceptibility candidate 2"	D3DTV9	17	48723168-48724758	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"intestine: 11.2;prostate: 12.8;urinary bladder: 3.4"	"Group enriched"	"Detected in some"	5	"PC-3: 31.3;REH: 12.2"	"Cancer enriched"	"Detected in many"	8	"prostate cancer: 26.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Intracellular and membrane"						"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-2)"			"unprognostic (9.98e-2)"	"unprognostic (3.27e-2)"		"unprognostic (9.77e-2)"	"unprognostic (8.97e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"		"unprognostic (1.82e-1)"	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	5.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.8	11.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	31.3	12.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SLC14A1	"HsT1341, JK, RACH1, RACH2"	ENSG00000141469	"Solute carrier family 14 member 1 (Kidd blood group)"	Q13336	18	45687025-45752520	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 44.5;prostate: 64.7;urinary bladder: 29.6"	"Cell line enriched"	"Detected in some"	14	"RT4: 49.9"	"Group enriched"	"Detected in many"	5	"glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 2.4;gdTCR: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059570, HPA077233"	Supported		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA059570: AB_2684066, HPA077233: "	"unprognostic (2.04e-1)"	"unprognostic (2.56e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.93e-2)"	2.2	2.1	15.6	1.5	21.5	10.3	2.4	4.6	24.2	2.9	1.6	33.7	0.0	1.9	1.1	1.4	1.1	1.0	8.7	8.2	33.7	11.7	10.1	1.5	4.1	2.4	28.0	23.4	1.0	1.5	1.2	0.4	2.0	44.5	64.7	1.8	0.0	2.6	3.2	3.4	1.7	2.1	3.9	34.9	2.6	2.0	1.0	44.0	0.0	3.6	0.0	2.6	29.6	3.0	0.7	0.3	2.4	0.1	1.8	7.2	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	1.3	49.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.4	0.0	1.9	0.0	0.0	1.1	0.5	0.5	0.1	0.1	2.4	2.0	0.0	0.1	0.6	2.0	2.4	0.0	0.7	0.5	3.4	0.4	1.8	0.0	0.3	7.2	1.1	15.6	21.5	4.6	24.2	33.7	11.7	28.0	23.4	44.5	44.0
SP8		ENSG00000164651	"Sp8 transcription factor"	Q8IXZ3	7	20782283-20786886	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"prostate: 14.3"	"Cell line enhanced"	"Detected in some"		"HEK 293: 4.2;HUVEC TERT2: 5.8;NTERA-2: 12.0;PC-3: 20.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"basal ganglia: 15.7;olfactory region: 66.8"	"Region enriched"	"Detected in some"	11	"olfactory region: 72.4"	HPA054006	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA054006: AB_2682340"		"unprognostic (1.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.90e-4)"		"unprognostic (3.46e-1)"	"unprognostic (5.49e-1)"	"unprognostic (1.73e-2)"		"unprognostic (2.42e-2)"		"unprognostic (3.38e-1)"	"unprognostic (7.44e-2)"			0.1	0.1	2.3	0.1	2.8	0.1	0.2	0.1	3.2	0.3	0.3	1.9	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.4	0.5	0.3	0.1	0.2	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.2	0.7	14.3	0.1	0.0	0.1	0.1	0.1	2.4	0.8	0.1	0.2	0.2	0.3	0.5	0.7	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	4.2	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.8	0.1	0.0	0.0	0.0	0.0	0.7	12.0	20.2	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	2.6	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.8	0.1	3.2	2.4	0.5	0.1	1.7	0.7	0.7
TGM4	TGP	ENSG00000163810	"Transglutaminase 4"	P49221	3	44874608-44914990	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"prostate: 107.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.5;hTERT-HME1: 2.6;NB-4: 5.1;RPMI-8226: 3.6;SH-SY5Y: 2.8"	"Cancer enriched"	"Detected in single"	312	"prostate cancer: 75.4"	"Region enriched"	"Detected in single"	254	"cerebral cortex: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA032072, CAB033571"	Enhanced									"CAB033571: AB_2287329, HPA032072: AB_10603350"	"unprognostic (4.40e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.56e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.41e-2)"	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	25.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.6	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.1	2.6	0.3	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.2	0.0	0.0	3.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.7	0.7	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019829-95301475	"Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 35.0"	"Group enriched"	"Detected in many"	4	"HEL: 60.4;HMC-1: 66.1;RPTEC TERT1: 17.8"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002476	Enhanced		Approved	"Nucleoli,Golgi apparatus,Plasma membrane"				"Nucleoli, Plasma membrane"	"Nucleoli, Plasma membrane"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favourable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	3.2	1.7	3.8	11.8	4.7	2.9	6.2	1.0	4.6	4.4	11.6	10.3	3.9	4.1	5.8	16.4	3.0	8.6	10.3	3.5	5.7	3.9	19.6	1.9	13.8	7.4	6.6	2.2	7.2	3.5	7.0	2.8	1.8	7.4	35.0	7.3	6.0	3.3	5.2	7.6	4.5	7.4	11.1	6.5	3.8	8.2	3.8	7.0	3.4	6.6	3.1	5.8	25.6	13.4	3.6	4.1	1.0	4.8	4.1	3.6	3.4	4.4	7.8	1.3	2.3	2.4	3.2	0.3	3.6	3.6	3.2	2.8	10.8	3.3	2.5	2.3	4.8	6.0	2.0	1.7	4.0	7.3	3.0	60.4	2.4	2.1	5.0	6.9	66.1	2.4	0.8	2.3	4.7	4.1	6.2	0.1	4.3	1.4	1.2	1.1	1.5	1.9	1.8	3.6	6.5	17.8	10.0	3.2	2.3	1.2	0.2	2.5	0.0	3.7	6.7	3.4	2.2	2.8	4.2	0.0	0.0	1.0	6.5	3.9	1.6	0.6	1.2	0.4	3.2	1.2	2.7	3.6	2.6	3.6	4.1	2.7	1.6	3.5	1.0	4.1	4.8	0.7	3.3	3.4	3.8	4.7	1.0	4.6	5.7	3.9	6.6	2.2	7.4	7.0
AC004080.3		ENSG00000257184			7	27163535-27180013	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"cervix, uterine: 24.9;endometrium 1: 20.7;prostate: 12.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.8;BJ: 4.3;BJ hTERT+ SV40 Large T+: 1.5;HEK 293: 2.9;RPTEC TERT1: 2.2;U-937: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																								"unprognostic (4.27e-1)"									"unprognostic (4.63e-1)"		"unprognostic (4.49e-1)"				1.6	0.2	0.3	1.8	0.3	0.0	0.2	0.3	0.3	24.9	6.9	0.0	1.0	0.0	20.7	2.1	0.2	0.2	0.0	0.3	0.2	0.3	4.7	0.3	0.2	0.0	0.3	0.0	0.3	0.3	0.0	0.3	4.6	0.0	12.9	1.1	0.0	0.2	1.2	6.9	0.3	0.5	6.7	0.2	0.2	0.2	1.0	0.0	0.0	0.3	0.0	0.0	7.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.2	0.2	4.3	0.8	1.5	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.0	0.0	0.0
AC078864.2		ENSG00000284791			12	52079696-52108239	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"lung: 23.3;prostate: 18.7;testis: 15.3"	"Group enriched"	"Detected in some"	5	"HHSteC: 2.4;MOLT-4: 1.6;RPMI-8226: 1.8"									"Cell type enriched"	"Detected in single"	87	"plasmacytoid DC: 8.7"	"Lineage enriched"	"Detected in single"	87	"dendritic cells: 8.7"					"Low region specificity"	"Detected in all"																															0.0	0.0	0.0	3.1	0.3	0.0	0.0	0.0	1.2	1.1	1.9	0.0	0.0	0.8	0.2	0.1	3.0	0.0	1.4	2.2	0.0		0.0	0.1	23.3	0.6	0.9	0.0	4.1	0.3	0.0	0.0	0.8	0.0	18.7	1.4	0.0	0.0	0.6	0.1	0.0	1.4	4.3	0.6	9.1	1.1	15.3	0.0	0.0	0.0	0.2	2.5	4.8	1.5	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0										
AL032819.3		ENSG00000284395			16	1431035-1433397	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"intestine: 4.1;prostate: 5.2;salivary gland: 2.5;stomach 1: 4.5"	"Cell line enriched"	"Detected in single"	30	"SCLC-21H: 27.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.2	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	2.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.2	0.0	0.4	2.5	0.0	0.2	0.3	2.1	1.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	27.1	0.2	0.0	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
ALKAL1	"AUGB, FAM150A, UNQ9433"	ENSG00000196711	"ALK and LTK ligand 1"	Q6UXT8	8	52534037-52565507	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 8.7;prostate: 6.8;urinary bladder: 9.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.1;HMC-1: 1.5;NTERA-2: 1.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Low region specificity"	"Detected in all"			HPA027368	Uncertain				"Secreted - unknown location"					"HPA027368: AB_10602317"			"unprognostic (1.18e-1)"	"unprognostic (1.13e-4)"				"unprognostic (9.47e-2)"		"unprognostic (9.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.70e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.58e-3)"	0.0	0.0	0.3	1.6	0.2	0.0	0.0	0.0	0.4	3.2	3.0	0.0	0.0	1.5	0.1	0.0	3.9	0.6	8.7	0.0	0.1	0.2	0.3	1.1	1.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.3	0.2	6.8	0.3	0.0	2.4	0.0	0.0	0.2	2.2	4.6	0.2	0.0	1.0	0.4	0.3	0.3	6.0	0.0	0.0	9.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.1	0.2	0.2	0.0	0.2	0.3
ALOX15B	15-LOX-2	ENSG00000179593	"Arachidonate 15-lipoxygenase, type B"	O15296	17	8039017-8049134	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 6.0;HSkMC: 12.7;hTCEpi: 26.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 91.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 6.1;myeloid DC: 6.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 6.8;monocytes: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010562	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA010562: AB_2668305"	"unprognostic (1.76e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.49e-2)"	8.9	0.6	0.4	0.7	0.6	0.3	57.4	0.1	0.4	7.6	4.6	0.1	0.0	0.2	0.3	0.7	30.6	0.8	0.5	0.2	1.3	0.0	2.9	0.7	44.0	7.1	1.8	0.3	0.8	0.8	0.2	0.9	0.7	1.3	35.9	0.3	0.1	3.6	0.2	0.3	15.4	1.9	0.2	4.1	3.1	1.6	1.0	2.0	0.5	0.8	6.6	4.1	1.1	12.9	0.0	6.8	0.2	6.1	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	12.7	26.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.7	0.0	0.2	0.0	1.7	0.4	0.6	0.1	0.4	1.3	0.0	1.8	0.3	1.3	2.0
AMD1	SAMDC	ENSG00000123505	"Adenosylmethionine decarboxylase 1"	P17707	6	110874770-110895713	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 104.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029281, HPA029282"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA029281: AB_10600101, HPA029282: AB_10599965"	"prognostic unfavourable (3.87e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (1.91e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.20e-1)"	"prognostic favourable (4.28e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.71e-2)"	16.7	15.2	29.7	16.9	35.6	38.1	17.8	27.3	34.2	18.6	18.6	45.7	12.5	14.9	18.9	14.2	28.9	14.7	17.5	18.5	32.5	21.5	25.2	16.9	16.9	18.5	39.0	22.0	16.9	20.2	21.8	26.2	33.8	32.7	104.7	19.4	12.8	17.5	19.2	15.3	14.5	13.5	18.4	38.3	16.7	18.4	15.8	46.0	19.4	25.5	20.1	24.6	12.6	16.8	6.6	12.9	42.0	14.0	6.1	9.2	6.5	20.6	14.1	17.3	32.7	26.2	16.6	22.6	29.7	32.9	23.2	27.4	22.4	13.0	36.4	14.4	18.8	14.2	40.8	26.9	32.0	21.3	23.6	37.7	12.9	23.5	15.6	32.5	22.6	11.2	24.9	16.0	32.4	20.2	28.1	31.8	39.0	12.5	43.2	25.0	21.2	12.9	23.8	17.4	21.6	26.3	27.7	22.2	15.8	18.1	23.0	26.2	14.8	27.9	13.2	15.4	11.6	82.0	32.0	8.7	14.1	37.3	17.7	26.0	19.7	15.0	9.8	14.7	7.6	11.6	8.9	6.3	7.6	8.7	12.9	6.6	9.2	9.0	42.0	6.1	14.0	5.8	8.8	6.5	29.7	35.6	27.3	34.2	32.5	21.5	39.0	22.0	32.7	46.0
AMELY	AMGL	ENSG00000099721	"Amelogenin, Y-linked"	Q99218	Y	6865918-6874027	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.2;prostate: 1.2;thyroid gland: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																	"unprognostic (1.62e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0		0.0	0.9	0.0	0.0	0.2		1.2	0.0		0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8			2.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ANO7	"IPCA-5, NGEP, PCANAP5, PCANAP5L, TMEM16G"	ENSG00000146205	"Anoctamin 7"	Q6IWH7	2	241188509-241225377	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.3;prostate: 44.7;stomach 1: 15.1"	"Group enriched"	"Detected in some"	5	"BEWO: 6.0;Hep G2: 5.8"	"Cancer enriched"	"Detected in many"	19	"prostate cancer: 32.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"							HPA078464	Enhanced				"Intracellular and membrane"					"HPA078464: "	"unprognostic (1.93e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.94e-2)"	"unprognostic (4.82e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.53e-2)"	0.2	0.0	0.3	6.5	0.4	1.7	0.2	0.2	0.4	0.3	17.3	0.3	0.2	5.3	0.2	0.2	0.2	0.1	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	44.7	4.9	0.2	2.3	0.2	0.2	0.0	17.3	0.5	0.3	0.2	15.1	0.2	0.2	0.2	0.2	0.7	1.0	0.3	0.2	0.0	0.0	0.0	0.8	2.2	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.0	6.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.5	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	1.1	0.2	0.3	0.0	0.0	1.1	0.0	0.0	0.4	0.5	0.0	0.1	0.3	0.3	0.0	1.0	0.0	0.0	1.1	0.6	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.1	0.3	0.4	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2
APELA	"ELA, Ende, tdl"	ENSG00000248329	"Apelin receptor early endogenous ligand"	P0DMC3	4	164877004-164898965	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 7.8;prostate: 8.2"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 29.4"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (2.97e-2)"	"unprognostic (6.97e-2)"	"unprognostic (9.83e-4)"	"unprognostic (8.92e-3)"		"unprognostic (1.43e-3)"		"unprognostic (4.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.95e-4)"	0.0	0.0	0.0	0.1	0.0	0.2	2.8	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0		3.9	0.0	1.5	0.1	0.0	2.2	0.7	0.0	0.0	0.0	7.8	0.0	8.2	0.0	0.0	1.9	0.0	0.0	1.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.4	0.0	0.6	0.6	2.5	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.1	0.0	0.0	0.1	0.0	0.7	0.3	0.7	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.6	0.3	0.3	2.5	0.3	0.0	0.6	0.2	0.0										
ARG2		ENSG00000081181	"Arginase 2"	P78540	14	67619798-67651720	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 53.7;thyroid gland: 75.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 25.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000663, CAB009435"	Enhanced		Supported	Mitochondria				Mitochondria	Mitochondria	"CAB009435: AB_2059089, HPA000663: AB_1078192"	"unprognostic (8.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-3)"	"unprognostic (4.62e-3)"	"unprognostic (5.37e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.39e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.26e-1)"	1.5	3.9	2.4	1.7	6.4	0.6	2.7	8.3	5.3	9.3	5.4	0.5	2.0	2.1	3.7	2.3	7.3	0.8	4.9	2.1	3.3	5.5	41.4	2.0	1.7	0.6	3.2	1.7	8.8	2.6	32.1	22.5	4.4	4.6	53.7	1.1	3.4	26.6	3.8	17.2	0.8	10.4	2.2	3.9	0.7	1.4	1.9	2.1	0.1	75.4	13.6	2.2	5.3	4.1	2.5	1.7	2.0	1.4	0.3	2.9	3.4	3.5	0.5	6.2	4.0	0.9	0.0	8.4	2.8	7.5	9.1	15.4	15.3	1.8	6.0	0.7	1.8	0.8	25.0	11.3	11.0	0.2	6.2	2.7	1.1	17.5	2.7	0.6	16.4	0.4	14.8	4.4	21.6	15.3	7.9	0.0	0.6	1.7	0.9	0.6	11.8	0.2	0.2	0.8	6.9	7.4	6.0	13.8	5.2	1.7	1.7	2.6	6.4	0.2	3.1	2.7	6.9	0.2	2.0	0.5	0.9	2.0	5.5	3.1	4.6	0.3	1.4	2.0	1.1	0.5	0.5	0.7	0.3	0.9	1.7	2.5	0.6	0.6	1.7	0.3	1.2	0.1	2.9	3.4	2.4	6.4	8.3	5.3	3.3	5.5	3.2	1.7	4.6	2.1
BMP5		ENSG00000112175	"Bone morphogenetic protein 5"	P22003	6	55753645-55875564	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.7;prostate: 29.4;retina: 21.2"	"Group enriched"	"Detected in some"	11	"AF22: 22.1;U-2 OS: 17.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"						"unprognostic (2.84e-4)"		"unprognostic (9.07e-4)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.39e-3)"		"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.76e-2)"	2.1	0.6	0.2	3.3	0.2	0.1	1.5	0.7	0.7	0.2	4.3	0.0	0.0	5.0	0.1	0.2	1.9	0.2	1.5	3.4	0.3	0.2	1.6	1.9	14.3	0.2	2.0	1.4	0.2	1.2	0.1	5.0	42.7	5.2	29.4	4.7	21.2	1.7	0.0	7.0	0.2	10.2	5.5	3.6	0.1	1.9	0.2	0.0	0.0	1.5	5.0	0.1	11.8	1.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.7	0.3	0.2	2.0	1.4	5.2	0.0
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757968-95158448	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.0;ductus deferens: 25.1;prostate: 25.3;seminal vesicle: 32.0"	"Cell line enhanced"	"Detected in many"		"A549: 18.3;MCF7: 9.2;SH-SY5Y: 15.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favourable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	1.1	5.6	12.7	0.8	15.0	0.7	1.7	11.6	12.7	28.0	1.2	5.5	25.1	0.7	5.3	3.2	1.1	14.3	3.4	1.3	13.4	5.9	9.3	1.4	2.4	0.5	5.4	8.6	7.6	1.7	0.6	2.4	1.2	12.1	25.3	0.8	0.7	1.4	32.0	3.3	1.4	0.6	1.2	7.5	1.4	2.8	4.3	11.2	10.8	0.8	0.1	0.6	0.7	0.7	0.4	0.5	1.9	0.9	0.8	1.6	0.3	0.0	18.3	4.9	0.0	1.9	4.5	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.8	1.0	2.9	6.7	0.0	0.0	4.5	0.0	1.1	0.0	0.5	0.4	0.0	2.8	7.5	2.8	5.6	0.0	0.0	0.0	7.0	9.2	0.6	0.1	1.8	3.1	0.1	2.7	0.1	3.5	0.1	0.2	15.3	0.2	2.5	2.5	1.9	0.0	0.0	3.9	3.1	0.1	3.3	0.0	0.0	0.0	1.5	0.0	0.4	1.9	0.3	0.5	0.4	0.5	0.7	0.4	0.6	0.3	0.3	0.3	0.5	0.5	0.8	0.8	0.9	0.5	1.6	0.3	12.7	15.0	11.6	11.8	13.4	5.9	5.4	8.6	12.1	11.2
CACNG4	"MGC11138, MGC24983"	ENSG00000075461	"Calcium voltage-gated channel auxiliary subunit gamma 4"	Q9UBN1	17	66964910-67033398	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.8;prostate: 16.5"	"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 95.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 159.8"	"HPA005803, HPA065370"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA005803: AB_2667439, HPA065370: AB_2685480"	"unprognostic (1.27e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.85e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.38e-10)"	"unprognostic (8.57e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.28e-1)"	0.7	1.8	16.0	0.8	32.3	0.7	8.1	3.5	37.8	1.2	0.9	11.4	0.2	1.0	1.2	0.8	0.8	6.2	1.2	0.7	9.6	12.9	0.8	0.7	8.0	0.7	7.5	7.1	0.7	1.2	4.9	0.1	1.6	6.8	16.5	0.8	0.1	0.9	2.4	0.8	0.9	0.9	2.0	4.2	0.7	1.7	0.9	10.3	0.0	0.7	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	3.8	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	3.8	0.0	0.0	0.1	2.0	0.0	2.6	3.8	95.2	0.8	2.5	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	32.3	3.5	13.0	9.6	12.9	7.5	7.1	6.8	10.3
CDH26	VR20	ENSG00000124215	"Cadherin 26"	Q8IXH8	20	59958427-60034011	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.1;prostate: 15.3"	"Cell line enriched"	"Detected in some"	6	"RT4: 33.9"	"Group enriched"	"Detected in some"	6	"cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;eosinophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA015722, HPA047578"	Uncertain		Supported	"Plasma membrane,Microtubules"				"Plasma membrane"	"Plasma membrane"	"HPA015722: AB_2077659, HPA047578: AB_2680091"	"unprognostic (2.42e-1)"	"prognostic favourable (7.62e-4)"	"unprognostic (4.71e-4)"	"unprognostic (8.17e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"prognostic favourable (3.75e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-4)"	"unprognostic (8.24e-3)"	"unprognostic (9.96e-7)"	"unprognostic (1.85e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	0.8	0.5	0.8	0.7	1.2	1.3	0.8	2.0	1.1	3.8	0.7	0.7	0.7	0.5	1.3	0.7	3.8	2.5	0.7	0.7	1.2	1.0	0.7	0.7	2.9	0.7	1.3	0.7	2.0	0.7	0.7	1.9	0.7	1.4	15.3	0.4	1.4	2.8	0.7	1.0	0.4	0.7	0.7	1.6	0.7	1.9	0.7	0.7	4.2	0.7	0.7	16.1	6.2	1.3	0.0	0.9	1.6	1.4	0.0	0.2	0.4	0.0	0.5	0.1	0.0	0.4	0.2	0.3	0.1	0.0	0.1	0.0	0.6	0.6	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.2	0.2	0.1	1.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.4	0.4	0.1	0.0	0.0	0.6	0.0	33.9	0.7	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.8	0.0	0.0	1.4	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	1.2	2.0	1.1	1.2	1.0	1.3	0.7	1.4	0.7
CLEC3A	CLECSF1	ENSG00000166509	"C-type lectin domain family 3 member A"		16	78022515-78066761	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"breast: 14.6;prostate: 8.6;smooth muscle: 17.1;urinary bladder: 17.2"	"Group enriched"	"Detected in some"	4	"SK-BR-3: 7.3;T-47d: 20.9"	"Cancer enriched"	"Detected in some"	102	"breast cancer: 78.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 0.5"	"Low region specificity"	"Detected in single"			HPA051511	Uncertain				"Secreted to extracellular matrix"					"HPA051511: AB_2681514"	"prognostic unfavourable (1.61e-4)"				"unprognostic (1.60e-1)"							"unprognostic (2.42e-1)"		"unprognostic (1.25e-1)"	"unprognostic (4.95e-2)"		"unprognostic (3.80e-2)"	0.1	0.1	0.1	1.8	0.3	0.0	14.6	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	4.6	0.3	0.1	1.1	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.4	8.6	0.0	3.3	0.1	0.0	0.1	0.1	0.1	17.1	0.1	0.1	0.8	0.1	0.0	0.0	0.1	1.9	0.0	17.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.8	0.1	1.1	0.1	0.0	0.4	0.0
COL9A1		ENSG00000112280	"Collagen type IX alpha 1 chain"	P20849	6	70215061-70303083	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 29.6;retina: 52.6"	"Group enriched"	"Detected in some"	6	"AF22: 23.2;NTERA-2: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA074749	Enhanced				"Secreted to extracellular matrix"					"HPA074749: AB_2732266"	"unprognostic (2.18e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.32e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.62e-2)"	0.7	0.6	8.5	0.7	7.5	0.5	0.6	3.6	4.7	0.6	1.1	7.2	0.0	1.8	1.1	0.8	0.8	0.7	1.1	5.6	8.4	9.4	1.1	0.5	0.6	0.6	10.3	1.7	0.6	0.5	0.9	3.3	0.6	5.6	29.6	1.4	52.6	3.0	1.1	0.6	0.6	2.0	0.9	5.3	0.6	2.6	4.1	6.9	0.0	1.0	0.2	0.7	0.7	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	7.5	3.6	4.7	8.4	9.4	10.3	1.7	5.6	6.9
CPA6	CPAH	ENSG00000165078	"Carboxypeptidase A6"	Q8N4T0	8	67422038-67746385	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2;prostate: 10.6;retina: 13.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;CACO-2: 6.2;EFO-21: 3.5;Hep G2: 9.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"olfactory region: 15.5"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"						"unprognostic (2.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.57e-4)"	"unprognostic (9.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-2)"	0.2	0.1	0.1	9.8	0.1	0.2	0.2	0.1	0.1	9.4	16.2	0.7	0.8	0.2	8.3	1.7	3.7	0.2	0.3	0.1	0.2	0.1	0.3	0.1	0.7	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.3	0.3	10.6	7.2	13.0	0.1	0.7	0.1	0.2	1.3	3.4	0.7	0.3	0.5	1.3	0.0	0.0	0.2	1.5	0.6	4.1	5.5	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	3.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.3	0.0
CPAMD8	"K-CAP, KIAA1283, VIP"	ENSG00000160111	"C3 and PZP like, alpha-2-macroglobulin domain containing 8"	Q8IZJ3	19	16892947-17026815	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 19.3;retina: 23.7;seminal vesicle: 30.5"	"Group enriched"	"Detected in some"	7	"BEWO: 14.4;EFO-21: 9.3;T-47d: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in single"			"HPA031327, HPA031328, HPA031329, HPA031330"	Uncertain		Uncertain	"Focal adhesion sites"	"Secreted to blood"	180000	180000	"Focal adhesion sites"	"Focal adhesion sites"	"HPA031327: AB_2673829, HPA031328: AB_2673830, HPA031329: , HPA031330: AB_10603788"	"unprognostic (4.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.85e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-2)"	3.1	1.3	1.0	0.4	2.3	0.2	3.6	0.6	2.3	5.3	0.4	2.9	6.5	0.2	1.5	8.2	0.6	0.6	0.4	7.0	1.2	1.3	8.9	0.5	11.5	1.5	4.9	0.4	0.6	0.4	3.5	2.0	3.1	5.1	19.3	0.0	23.7	1.1	30.5	1.7	0.4	0.4	0.4	5.6	1.1	0.1	0.9	2.8	0.9	11.6	1.4	0.4	1.2	1.4	0.2	0.0	0.6	1.5	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	14.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	9.3	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.2	0.5	0.0	1.4	0.0	0.1	0.3	1.9	0.0	0.0	0.0	0.4	0.0	25.2	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	2.3	0.6	2.3	1.2	1.3	4.9	0.4	5.1	2.8
CPLX3	CPX-III	ENSG00000213578	"Complexin 3"	Q8WVH0	15	74826547-74831802	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.8;lymphoid tissue: 31.8;prostate: 56.4;retina: 32.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.5;Karpas-707: 4.8;SK-BR-3: 2.7;U-266/84: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			CAB079003		Supported								"CAB079003: "																		0.4	2.5	6.4	0.5	7.4	0.4	0.4	20.8	19.6	0.5	0.5	3.3	0.0	0.4	0.4	0.5	0.5	0.4	0.4	13.4	6.4	0.8	0.4	0.4	0.4	0.5	0.6	7.9	0.4	0.4	0.4	1.7	0.4	8.2	56.4	0.4	32.8	9.8	0.4	0.4	0.5	0.6	0.4	1.0	31.8	4.6	2.2	1.2	0.0	0.4	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.1	0.0	5.5	0.1	0.0	0.2	0.1	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.2	0.0	0.0	0.0	4.8	0.0	0.1	0.0	0.9	0.1	0.3	0.2	0.0	0.4	0.0	0.1	2.1	0.1	0.0	2.7	1.1	1.6	0.0	0.0	0.1	0.1	0.5	0.0	1.3	3.1	2.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	7.4	20.8	19.6	6.4	0.8	0.6	7.9	8.2	1.2
CPNE4	"COPN4, CPN4"	ENSG00000196353	"Copine 4"	Q96A23	3	131533555-132285410	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;prostate: 35.7"	"Cell line enhanced"	"Detected in some"		"A549: 9.7;AF22: 9.1;Karpas-707: 2.7;RT4: 3.1"	"Cancer enriched"	"Detected in some"	6	"prostate cancer: 22.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	33	"granulocytes: 3.2"	"Low region specificity"	"Detected in many"							"HPA032036, HPA078300"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA032036: , HPA078300: AB_2732377"	"unprognostic (7.38e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.51e-1)"	1.4	1.4	7.0	0.8	11.6	0.8	0.7	0.4	27.2	1.0	1.1	2.5	0.7	1.6	0.9	1.6	1.1	1.2	0.7	1.9	17.5	5.3	2.1	0.8	1.2	0.7	1.3	11.8	0.7	0.8	3.8	9.5	0.7	3.1	35.7	1.0	0.1	1.1	6.0	0.6	1.0	1.4	1.2	4.6	1.8	1.4	2.3	3.6	0.0	1.1	0.0	0.7	0.7	1.1	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.0	9.7	9.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	2.7	1.3	0.6	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.6	3.1	1.3	0.6	0.0	1.2	0.0	0.0	0.0	0.0	1.1	2.3	0.3	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	7.0	11.6	0.4	27.2	17.5	5.3	1.3	11.8	3.1	3.6
CREB3L4	"AIbZIP, ATCE1, CREB3, CREB4, hJAL"	ENSG00000143578	"CAMP responsive element binding protein 3 like 4"	Q8TEY5	1	153967534-153974363	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 49.9"	"Group enriched"	"Detected in many"	4	"MCF7: 24.8;SK-BR-3: 54.8;T-47d: 44.0"	"Group enriched"	"Detected in all"	5	"breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038122	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"				"Nucleoplasm, Nuclear membrane"	"Nucleoplasm, Nuclear membrane"	"HPA038122: AB_10669516"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.13e-3)"	"prognostic favourable (7.21e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.34e-3)"	4.3	5.0	3.2	5.4	4.0	2.9	22.6	5.7	3.5	14.6	5.1	4.3	18.3	5.0	8.5	12.1	5.1	8.8	7.9	3.2	2.5	1.4	4.5	8.4	4.7	5.5	3.2	3.0	9.3	7.9	3.7	3.4	6.6	4.0	49.9	6.9	4.7	24.7	11.4	6.1	5.9	5.3	3.4	3.3	4.5	13.2	4.3	3.0	12.9	12.5	6.6	8.3	4.5	15.1	6.6	7.3	2.6	3.5	10.9	6.0	3.1	2.2	3.3	3.1	3.4	2.2	3.2	7.8	1.9	2.2	2.6	2.3	1.5	9.6	4.2	10.1	0.8	3.7	4.6	3.0	1.4	3.4	1.8	3.1	3.5	2.7	1.8	1.4	2.7	3.5	2.9	2.5	5.7	2.3	2.4	5.3	1.2	24.8	2.7	1.1	2.1	4.0	6.1	3.2	7.8	2.8	1.6	5.8	6.3	2.0	54.8	5.2	44.0	4.5	1.4	0.8	2.4	1.6	1.5	9.9	5.1	3.1	1.7	2.5	2.5	2.2	3.5	2.6	4.5	1.5	6.0	6.3	2.6	3.3	6.4	6.6	2.5	4.8	0.1	10.9	2.1	7.3	2.1	3.1	3.2	4.0	5.7	3.5	2.5	1.4	3.2	3.0	4.0	3.0
CUX2	"CDP2, CUTL2, KIAA0293"	ENSG00000111249	"Cut like homeobox 2"	O14529	12	111034024-111350554	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.9;brain: 13.2;liver: 21.5;prostate: 13.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 7.3;HDLM-2: 3.1;hTERT-HME1: 4.0;SCLC-21H: 7.4;SH-SY5Y: 15.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 11.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	100	"plasmacytoid DC: 9.9"	"Lineage enriched"	"Detected in single"	100	"dendritic cells: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.87e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.83e-5)"	"unprognostic (2.67e-1)"	"unprognostic (3.54e-3)"	"unprognostic (4.31e-2)"	"unprognostic (9.03e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.90e-2)"	0.2	0.2	2.9	0.4	4.8	0.3	2.3	1.2	13.2	1.1	0.3	0.3	2.8	0.3	0.3	0.5	0.3	0.2	0.2	0.2	1.9	2.1	0.2	21.5	0.2	0.6	2.7	3.1	0.1	0.2	0.1	1.9	0.2	1.0	13.6	0.2	0.6	0.1	5.4	0.2	0.2	0.3	0.1	0.4	0.4	1.2	0.6	0.4	0.0	4.9	0.0	0.7	0.3	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	7.3	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.2	0.0	0.1	0.0	0.1	7.4	15.9	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	2.9	4.8	1.2	13.2	1.9	2.1	2.7	3.1	1.0	0.4
CWH43	"CWH43-C, FLJ21511"	ENSG00000109182	"Cell wall biogenesis 43 C-terminal homolog"	Q9H720	4	48986247-49062081	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 26.1;seminal vesicle: 22.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;NB-4: 1.4;SH-SY5Y: 1.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 20.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042814, HPA048140"	Uncertain									"HPA042814: AB_2678182, HPA048140: AB_2680280"	"unprognostic (9.38e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.14e-2)"	"prognostic favourable (1.32e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.24e-1)"	"prognostic favourable (2.29e-11)"	"unprognostic (5.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-2)"	0.1	0.0	0.1	9.3	0.1	0.0	1.0	0.1	0.2	5.1	9.7	0.2	11.1	0.0	2.0	2.2	19.8	8.6	0.4	0.1	0.1	0.1	7.6	1.1	0.8	0.1	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.1	26.1	9.1	0.4	2.7	22.9	0.1	16.9	0.1	1.9	0.1	0.1	5.2	0.7	0.1	0.3	10.6	12.6	3.6	3.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021117-76023497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 36.2;lymphoid tissue: 34.8;prostate: 34.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.6;BJ hTERT+ SV40 Large T+: 3.6;BJ hTERT+ SV40 Large T+ RasG12V: 3.5;Daudi: 3.1;RPMI-8226: 6.6;RT4: 3.7;THP-1: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 10.6;intermediate monocyte: 25.5;non-classical monocyte: 15.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 25.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favourable (1.12e-5)"	"prognostic unfavourable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.3	2.1	2.7	34.8	2.5	0.0	7.3	1.8	4.8	8.1	3.5	0.9	0.2	3.8	2.3	6.7	4.7	1.2	3.8	7.6	1.2	1.2	7.5	10.6	36.2	21.7	3.2	1.6	3.9	1.2	0.0	2.3	5.6	3.0	34.6	6.0	2.6	9.1	2.1	7.3	2.1	4.1	5.5	11.3	15.8	6.4	1.3	0.9	15.0	25.7	5.4	9.2	9.2	2.2	0.5	1.6	0.6	25.5	0.0	0.1	3.7	0.7	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.6	3.6	3.5	0.3	0.1	3.1	0.4	0.0	0.0	0.0	0.2	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	6.6	0.1	3.7	0.0	0.0	0.0	0.7	2.1	0.2	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.9	0.0	0.0	10.6	0.0	0.0	25.5	0.0	0.5	0.1	0.0	1.6	0.0	0.0	0.0	0.6	0.0	15.9	0.0	0.0	3.7	2.7	2.5	1.8	4.8	1.2	1.2	3.2	1.6	3.0	0.9
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 48.8;RT4: 58.4;SK-BR-3: 285.8;U-2 OS: 93.6"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.7"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (6.45e-4)"	0.1	0.3	0.3	0.0	0.2	0.0	79.9	0.1	0.2	0.5	0.1	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.8	1.8	5.0	0.2	0.0	0.2	0.0	9.0	5.9	0.3	0.5	5.0	0.1	40.2	0.0	0.1	20.1	0.6	0.1	0.7	0.1	23.1	0.3	3.7	0.8	0.9	0.0	0.0	0.1	0.0	0.0	120.7	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	19.7	1.5	0.1	0.0	48.8	0.0	0.2	1.7	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	2.2	0.1	0.4	0.1	0.0	58.4	0.2	0.3	0.4	285.8	0.3	0.2	0.0	0.0	0.1	93.6	0.5	0.2	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.3	0.8	0.2	0.0	0.1	0.0
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107524-89482134	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 39.0"	"Cell line enriched"	"Detected in some"	6	"AF22: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"			"Nuclear membrane, Plasma membrane, Cytosol"	"Nuclear membrane, Plasma membrane, Cytosol"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	9.7	1.1	2.3	1.7	4.5	0.2	5.1	1.3	8.7	12.3	5.8	0.6	1.4	2.2	13.9	1.3	6.3	2.6	17.2	10.0	2.2	2.5	1.5	4.4	2.7	3.0	2.5	3.4	4.2	2.8	1.2	3.4	17.5	11.9	39.0	5.9	5.4	3.8	6.8	1.7	1.7	3.5	17.3	2.9	1.2	3.7	1.3	2.0	0.0	16.3	6.0	3.0	11.8	12.2	0.3	0.1	0.5	0.1	0.3	0.2	0.0	0.0	0.0	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.8	0.0	0.0	4.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	2.3	4.5	1.3	8.7	2.2	2.5	2.5	3.4	11.9	2.0
EVX1		ENSG00000106038	"Even-skipped homeobox 1"	P49640	7	27242700-27250493	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 6.5;prostate: 6.4;seminal vesicle: 6.7;urinary bladder: 8.9"	"Cell line enriched"	"Detected in some"	12	"RT4: 17.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	26	"pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"midbrain: 1.0;pons and medulla: 1.0"	"Region enriched"	"Detected in single"	9	"pons and medulla: 1.1"	HPA055132			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA055132: AB_2682707"	"unprognostic (2.73e-2)"	"unprognostic (3.59e-1)"	"unprognostic (4.31e-1)"		"unprognostic (5.16e-2)"		"unprognostic (1.76e-3)"	"unprognostic (2.08e-2)"			"unprognostic (8.48e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.26e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.83e-2)"	0.1	6.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.2	0.6	0.1	0.1	0.0	0.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	3.0	6.4	0.7	0.1	0.1	6.7	0.1	0.0	0.1	1.9	0.1	0.1	0.0	1.7	0.1	0.1	0.1	0.1	0.1	8.9	5.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	3.0	0.1
EVX2		ENSG00000174279	"Even-skipped homeobox 2"	Q03828	2	176077472-176083913	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 3.4;prostate: 3.8;seminal vesicle: 5.0;testis: 6.1;vagina: 2.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;SCLC-21H: 1.5;SH-SY5Y: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"midbrain: 1.6;pons and medulla: 1.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 0.8"	HPA041576	Uncertain									"HPA041576: AB_10796347"		"unprognostic (2.27e-1)"	"unprognostic (1.68e-3)"		"unprognostic (1.83e-1)"				"unprognostic (3.41e-1)"	"unprognostic (5.75e-1)"		"unprognostic (3.13e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.32e-1)"		"unprognostic (4.93e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.9			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		3.8	1.8		0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1			0.0		0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAM237B		ENSG00000283267	"Family with sequence similarity 237 member B"		7	90316503-90321308	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"prostate: 1.1;testis: 1.7"	"Cell line enhanced"	"Detected in some"		"HSkMC: 1.0;U-266/70: 1.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hypothalamus: 1.9;thalamus: 5.4"	"Low region specificity"	"Detected in all"																															0.0	0.2		0.3		0.1	0.0		0.1	0.0	0.0			0.2	0.2	0.0	0.0	0.1	0.1	0.0			0.5	0.0	0.8	0.0			0.0	0.0	0.0		0.0		1.1	0.0		0.2	0.0	0.0	0.2	0.0	0.0		0.1	0.0	1.7			0.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.7	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FOLH1	"FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA"	ENSG00000086205	"Folate hydrolase 1"	Q04609	11	49146635-49208670	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.7;intestine: 111.2;prostate: 33.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.3;RPMI-8226: 3.7;SK-BR-3: 4.4;TIME: 2.8;WM-115: 5.3"	"Cancer enriched"	"Detected in many"	27	"prostate cancer: 142.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001451, HPA010593"	Enhanced									"CAB001451: AB_563979, HPA010593: AB_1079685"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (5.24e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.31e-2)"	"prognostic favourable (4.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavourable (1.30e-6)"	"unprognostic (4.81e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.04e-1)"	1.2	1.0	10.4	0.9	16.4	0.8	2.5	1.4	12.7	1.4	67.6	37.7	0.0	111.2	1.3	0.8	1.2	2.1	5.0	0.7	16.9	8.7	6.1	15.7	1.1	0.9	19.0	9.1	1.0	0.7	0.7	0.4	0.7	17.7	33.8	0.8	0.6	20.7	0.8	0.6	1.2	61.1	1.0	33.0	1.5	1.0	0.9	16.2	0.0	1.0	0.0	0.8	1.2	0.5	0.9	0.1	0.3	0.8	1.4	1.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.6	0.0	0.2	5.3	0.5	0.0	1.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	1.0	0.0	0.3	0.3	3.7	0.0	0.0	0.4	1.6	0.0	4.4	1.0	1.0	0.0	2.8	0.2	2.7	0.4	0.3	0.1	0.5	0.1	0.0	0.9	5.3	0.1	0.8	0.3	0.9	0.6	0.2	0.6	1.2	0.5	0.0	0.9	0.7	0.3	0.2	1.4	0.5	0.1	0.4	0.0	10.4	16.4	1.4	12.7	16.9	8.7	19.0	9.1	17.7	16.2
FOXA1	HNF3A	ENSG00000129514	"Forkhead box A1"	P55317	14	37589984-37596059	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 47.0;prostate: 44.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 16.3;MCF7: 35.4;PC-3: 24.7;RT4: 33.1;SK-BR-3: 33.5;T-47d: 47.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 127.0"	"Region enriched"	"Detected in single"	6	"midbrain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"hypothalamus: 1.0;midbrain: 1.3;thalamus: 1.1"	"Region enriched"	"Detected in some"	6	"midbrain: 6.1"	"CAB011595, HPA050505"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	Nucleoplasm	"CAB011595: AB_2104842, HPA050505: AB_2681148"	"unprognostic (1.61e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-2)"	"prognostic favourable (1.00e-4)"	0.1	0.0	0.1	6.1	0.1	0.0	23.5	0.1	0.3	1.5	9.4	0.1	0.1	4.6	0.1	0.5	7.2	1.3	6.5	0.1	0.1	0.3	0.4	47.0	13.2	0.1	2.0	0.1	0.6	0.2	0.0	1.1	0.1	0.2	44.4	6.0	0.2	9.4	0.7	0.1	0.7	5.1	2.4	0.1	0.1	13.0	0.6	0.1	0.2	0.1	4.4	9.9	12.5	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	7.3	0.9	0.0	0.5	0.0	8.2	4.6	1.1	0.0	0.0	8.1	0.0	1.4	16.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	35.4	0.0	0.1	0.0	24.7	0.0	0.3	0.1	3.4	33.1	4.2	0.0	1.6	33.5	0.0	47.5	0.1	0.0	0.3	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.3	2.0	0.1	0.2	0.1
GABRG3		ENSG00000182256	"Gamma-aminobutyric acid type A receptor gamma3 subunit"	Q99928	15	26971282-27541991	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.3;prostate: 13.5;testis: 16.6"	"Cell line enhanced"	"Detected in some"		"K-562: 4.9;PC-3: 6.3;SK-MEL-30: 4.1;U-2 OS: 2.9;U-266/70: 3.8;U-87 MG: 16.8"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054010	Supported									"HPA054010: AB_2682342"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"		"unprognostic (1.02e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (1.43e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	0.5	1.3	2.2	0.8	10.4	0.5	1.2	3.1	15.3	2.2	0.5	0.8	0.0	0.4	0.7	4.4	0.5	1.3	0.5	0.4	3.0	5.8	1.0	0.6	0.5	1.5	1.0	7.8	0.5	0.4	0.4	6.4	0.5	2.7	13.5	0.5	4.0	1.5	3.4	0.5	0.9	0.4	0.6	0.8	2.3	0.4	16.6	0.5	0.3	3.3	0.0	1.9	0.4	0.7	0.8	0.3	0.9	0.4	0.3	0.3	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.4	0.4	6.3	0.0	0.0	1.1	0.0	0.0	0.1	1.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.8	0.0	0.0	16.8	0.1	0.0	0.4	0.4	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.0	0.8	0.3	0.1	0.9	0.3	0.1	0.3	0.1	0.0	2.2	10.4	3.1	15.3	3.0	5.8	1.0	7.8	2.7	0.5
GLB1L3	FLJ90231	ENSG00000166105	"Galactosidase beta 1 like 3"	Q8NCI6	11	134274245-134319564	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.1;prostate: 18.5;seminal vesicle: 10.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.8;HEK 293: 8.0;MOLT-4: 2.9;NTERA-2: 4.9;PC-3: 6.6;SCLC-21H: 10.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"gdTCR: 2.3;memory CD4 T-cell: 5.7;memory CD8 T-cell: 3.5;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6;T-reg: 2.4"	"Lineage enriched"	"Detected in single"	57	"T-cells: 5.7"	"Not detected"	"Not detected"							HPA039916	Uncertain									"HPA039916: AB_2676746"	"unprognostic (1.64e-3)"	"unprognostic (7.80e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (8.69e-3)"	"prognostic favourable (1.97e-4)"	"unprognostic (6.58e-3)"	"unprognostic (3.81e-1)"	"unprognostic (6.95e-3)"	"unprognostic (9.73e-2)"	"unprognostic (1.52e-5)"	"unprognostic (1.39e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.07e-1)"	0.5	2.7	4.0	1.2	19.1	0.6	1.2	10.3	14.4	0.8	1.2	0.0	0.0	0.5	3.8	0.4	0.5	0.4	0.5	0.4	2.7	2.6	1.3	0.4	0.5	2.1	1.4	6.1	0.4	0.6	0.4	1.1	0.5	5.8	18.5	0.5	1.0	3.4	10.8	0.5	5.4	0.5	0.5	0.6	0.6	0.6	2.4	1.4	0.0	3.4	0.0	0.8	0.9	1.2	0.0	0.0	0.0	0.0	0.0	5.7	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.3	0.0	2.8	8.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	4.9	6.6	0.0	0.0	0.0	0.0	0.0	10.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.3	0.0	5.7	3.5	0.0	0.0	4.8	3.6	0.0	0.0	0.0	0.0	2.4	1.0	4.0	19.1	10.3	14.4	2.7	2.6	1.4	6.1	5.8	1.4
GLIS1	FLJ36155	ENSG00000174332	"GLIS family zinc finger 1"	Q8NBF1	1	53506237-53738106	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.9;seminal vesicle: 14.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.2;BJ hTERT+: 6.2;PC-3: 9.9;U-138 MG: 7.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001409	Uncertain									"HPA001409: AB_1078974"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.37e-4)"	"unprognostic (1.98e-4)"	1.1	0.1	0.5	0.6	1.2	0.0	0.9	3.9	1.6	4.2	0.5	0.5	0.5	0.6	1.4	1.0	0.6	0.8	1.0	1.0	2.3	0.7	3.3	0.5	0.5	0.5	0.5	0.5	1.0	0.5	0.0	0.5	1.2	0.8	8.9	0.1	5.5	0.5	14.7	0.5	1.7	0.6	0.5	0.5	0.5	0.9	4.1	0.5	0.5	0.5	0.5	1.0	2.7	4.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	4.0	5.2	0.0	2.7	6.2	2.4	1.8	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.8	0.0	1.7	0.0	1.8	0.1	1.4	0.0	0.0	3.6	0.2	3.0	2.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	9.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	1.3	0.1	1.8	0.0	0.0	4.4	0.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	3.9	1.6	2.3	0.7	0.5	0.5	0.8	0.5
HHIPL2	"FLJ13840, KIAA1822L"	ENSG00000143512	"HHIP like 2"	Q6UWX4	1	222522258-222548103	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 9.4;testis: 10.4;thyroid gland: 4.6"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;Hep G2: 5.4;RH-30: 20.3;U-87 MG: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059673	Enhanced		Uncertain	Mitochondria,Cytosol	"Secreted in other tissues"			Mitochondria	Mitochondria	"HPA059673: AB_2684100"	"unprognostic (1.35e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.91e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.74e-3)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (8.07e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.14e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-2)"	"unprognostic (4.21e-4)"	"unprognostic (2.30e-3)"	"unprognostic (8.38e-2)"	0.3	0.7	0.0	0.1	0.6	0.1	0.2	0.1	1.4	0.7	0.0	0.6	0.0	0.0	0.1	0.5	0.5	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.9	9.4	0.2	0.3	1.9	3.9	0.0	0.1	0.1	0.0	0.0	0.1	0.1	10.4	0.0	0.0	4.6	0.0	0.3	0.2	0.7	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.1	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	5.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.3	0.0	20.3	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	0.0	0.1	0.0	10.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.1	1.4	0.0	0.1	0.0	0.0	0.9	0.0
HIST2H3C	"H3, H3.2, H3/m, H3F2, H3FM, MGC9629"	ENSG00000203811	"Histone cluster 2 H3 family member c"	Q71DI3	1	149839538-149841193	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.8;brain: 5.1;prostate: 3.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.5;SiHa: 8.3;U-266/70: 7.3;U-266/84: 7.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"											"HPA042570, CAB069990"	Approved									"CAB069990: AB_10804539, HPA042570: AB_2678056"					"unprognostic (1.78e-1)"			"unprognostic (2.25e-1)"		"unprognostic (2.42e-1)"				"unprognostic (1.36e-2)"				0.4	0.5	0.7	0.4	1.4	3.8	0.0	5.1	2.9	0.1	0.3			0.8	0.2	0.0	0.4	1.0	0.0	1.4	0.7	0.2	0.1	0.6	0.3	0.5	0.3		0.0	1.9	0.0	0.1	0.3		3.6	0.0		0.9	0.0	0.2	0.5	0.6	0.0	0.4	0.4	1.1	1.4			0.1		0.0	0.4	0.6	0.4	0.6	1.6	0.2	0.2	0.1	0.2	0.5	3.2	0.6	0.4	0.1	0.0	1.1	0.5	0.1	0.7	0.1	0.5	0.6	0.3	0.5	0.0	2.6	0.0	0.1	0.2	0.8	5.5	0.5	2.5	0.1	0.0	0.4	1.5	0.0	0.0	0.1	0.2	0.1	2.5	3.1	0.1	2.2	1.5	2.0	1.7	1.3	1.3	0.3	1.5	0.0	0.3	4.9	1.1	8.3	2.3	0.4	1.4	1.8	0.0	0.6	4.7	0.3	0.4	7.3	7.2	1.7	0.5	0.6	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.1	1.6	0.2	0.2	0.6	0.0	0.2										
HOXA13	"HOX1, HOX1J"	ENSG00000106031	"Homeobox A13"	P31271	7	27193503-27200106	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 48.5;prostate: 25.1"	"Cell line enhanced"	"Detected in many"		"HAP1: 15.2;HEK 293: 21.1;PC-3: 10.5;RT4: 23.5;THP-1: 10.0;U-937: 11.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA069061			Supported	"Nucleoplasm,Intermediate filaments"				Nucleoplasm	Nucleoplasm	"HPA069061: "	"unprognostic (7.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.04e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.30e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.42e-11)"	"unprognostic (2.58e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-2)"	0.6	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	48.5	6.9	0.0	7.1	0.0	5.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	16.5	0.0	25.1	8.6	0.0	0.1	17.9	1.2	0.4	0.1	15.7	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	12.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	1.4	0.1	0.0	0.0	7.4	8.2	2.9	1.9	1.5	0.1	0.0	0.9	3.5	0.0	15.2	0.0	2.5	0.0	21.1	1.0	4.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	10.5	1.5	0.3	0.0	0.0	23.5	0.4	0.0	1.8	0.0	0.1	0.0	10.0	0.0	0.2	2.7	0.1	0.1	0.0	0.0	0.0	0.0	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
HOXD13	"HOX4I, SPD"	ENSG00000128714	"Homeobox D13"	P35453	2	176092891-176095938	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 14.0;intestine: 13.1;prostate: 13.8;seminal vesicle: 19.0;vagina: 15.0"	"Group enriched"	"Detected in some"	4	"HAP1: 9.6;HEK 293: 27.6;HL-60: 30.7;NB-4: 18.3;SCLC-21H: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064064			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA064064: AB_2685186"	"unprognostic (2.04e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (6.95e-5)"	"unprognostic (2.52e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.08e-2)"		"unprognostic (4.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.66e-1)"		"unprognostic (1.01e-2)"	"unprognostic (2.82e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.70e-2)"		"unprognostic (9.98e-3)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	14.0	13.1	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	13.8	8.8	0.1	0.1	19.0	0.6	0.0	0.1	3.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	3.8	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	1.5	0.0	27.6	4.2	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	18.3	0.9	1.5	0.0	0.1	0.0	0.0	0.2	8.0	1.9	1.9	0.0	4.4	0.0	0.0	0.0	1.0	0.0	0.4	2.5	0.0	0.0	0.0	1.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
KAZALD1	"FKSG28, FKSG40"	ENSG00000107821	"Kazal type serine peptidase inhibitor domain 1"	Q96I82	10	101061841-101068131	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.6;prostate: 24.0;retina: 22.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.3;T-47d: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	13	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011800	Uncertain				"Secreted to extracellular matrix"					"HPA011800: AB_1852082"	"unprognostic (3.34e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavourable (5.10e-4)"	"unprognostic (2.11e-1)"	2.6	0.6	0.8	3.2	0.5	0.1	2.6	0.3	1.0	10.3	2.3	0.4	2.9	3.3	5.2	10.6	1.6	2.0	3.0	7.7	1.0	0.4	1.9	0.4	2.4	2.8	0.6	0.3	1.9	1.1	1.6	3.6	1.1	1.5	24.0	2.0	22.5	8.3	3.0	4.8	1.7	3.7	5.6	0.5	20.6	8.7	1.8	0.3	0.6	2.5	5.7	2.3	3.0	3.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.2	1.7	22.3	1.9	6.7	1.7	4.1	4.7	1.1	1.0	4.9	1.8	0.2	2.4	4.1	0.4	1.5	0.0	0.2	2.6	0.8	0.3	4.9	4.7	0.4	0.3	2.0	0.9	0.3	0.1	0.8	0.1	0.6	2.4	0.7	3.7	0.1	1.4	0.5	9.1	9.5	8.3	0.3	0.4	1.1	0.3	1.0	0.5	0.7	1.3	28.5	0.6	0.1	0.6	1.9	0.3	1.1	0.7	2.1	2.0	1.0	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.3	1.0	1.0	0.4	0.6	0.3	1.5	0.3
MESP1	"bHLHc5, MGC10676"	ENSG00000166823	"Mesoderm posterior bHLH transcription factor 1"	Q9BRJ9	15	89748661-89751310	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 14.1;prostate: 10.9"	"Cell line enhanced"	"Detected in some"		"A-431: 5.6;HDLM-2: 4.9;HEK 293: 4.9;PC-3: 9.3;SCLC-21H: 4.3"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 6.3;prostate cancer: 26.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069981			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"HPA069981: AB_2686225"	"unprognostic (4.17e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.83e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-2)"	14.1	1.6	6.8	1.4	4.3	1.1	3.8	7.3	8.8	2.5	1.9	1.1	0.1	1.3	1.0	1.0	0.9	1.0	2.9	3.9	4.9	5.0	1.3	1.2	1.1	1.1	3.3	4.3	1.0	1.2	1.1	1.1	0.8	2.4	10.9	1.0	1.3	3.0	1.2	7.0	0.9	1.1	0.9	1.4	0.9	1.0	1.4	1.9	0.0	1.0	2.2	0.9	0.9	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	5.6	2.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.3	0.0	2.2	0.0	0.0	0.4	0.0	0.0	4.9	4.9	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.8	1.4	0.0	9.3	0.2	0.0	1.3	0.1	0.0	4.3	0.1	1.1	1.8	1.1	0.1	0.7	0.0	0.0	0.3	3.4	1.1	2.2	0.7	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	6.8	4.3	7.3	8.8	4.9	5.0	3.3	4.3	2.4	1.9
MKX	"C10orf48, IRXL1, MGC39616"	ENSG00000150051	"Mohawk homeobox"	Q8IYA7	10	27672875-27746060	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 21.3;prostate: 24.3"	"Cell line enhanced"	"Detected in some"		"BJ: 18.8;BJ hTERT+: 10.8;BJ hTERT+ SV40 Large T+: 12.4;BJ hTERT+ SV40 Large T+ RasG12V: 8.5;fHDF/TERT166: 53.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006927	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"	"Nucleoplasm, Nuclear speckles"	"HPA006927: AB_1853981"	"unprognostic (2.04e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.38e-3)"	3.7	3.2	1.6	1.4	2.1	0.3	3.0	2.6	5.9	4.9	4.3	1.4	0.9	0.5	1.8	3.4	1.8	7.1	2.7	0.8	1.4	2.5	0.6	1.9	1.2	0.5	2.7	1.4	21.3	1.0	0.3	13.9	0.3	6.7	24.3	1.5	2.9	0.9	7.7	0.5	1.0	0.7	10.6	2.7	0.8	3.4	1.3	0.1	0.0	4.5	0.5	0.3	8.7	1.6	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.8	10.8	12.4	8.5	0.0	0.0	0.0	0.0	53.9	0.0	0.1	0.0	3.3	0.0	1.2	0.0	3.4	0.0	0.5	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.2	1.6	0.0	0.2	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	1.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	2.6	5.9	1.4	2.5	2.7	1.4	6.7	0.1
MYH3	"HEMHC, MYHC-EMB, MYHSE1, SMHCE"	ENSG00000109063	"Myosin heavy chain 3"	P11055	17	10628526-10657309	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.1;prostate: 25.6;skeletal muscle: 18.5"	"Cell line enriched"	"Detected in some"	28	"HSkMC: 37.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.7"	"Low region specificity"	"Detected in some"			HPA021808	Enhanced					17000000	17000000			"HPA021808: AB_1854242"	"unprognostic (1.70e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.19e-4)"	"unprognostic (3.35e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.84e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.24e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.17e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.49e-1)"	1.0	0.5	0.7	0.8	1.0	0.6	0.8	1.9	0.8	2.2	4.1	0.6	3.5	0.9	1.9	13.2	21.1	1.0	0.6	0.6	0.9	0.6	0.8	1.8	0.6	1.0	0.9	0.6	1.4	1.3	0.5	0.7	1.1	0.6	25.6	0.9	0.6	0.7	16.2	18.5	1.5	1.4	16.5	1.2	1.6	0.8	2.8	0.6	1.8	2.3	1.7	2.0	8.5	2.6	1.0	0.1	0.0	0.1	0.9	0.7	0.0	0.1	0.6	0.4	0.6	0.6	0.2	0.6	0.4	0.2	0.3	0.3	0.6	0.1	0.4	0.2	0.2	0.6	0.3	0.1	0.6	0.4	0.5	0.5	0.1	0.9	0.2	0.3	0.8	37.0	0.2	0.4	0.4	0.0	0.2	0.0	0.1	0.4	0.5	1.3	0.5	0.4	0.5	0.5	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.2	0.0	0.6	0.1	0.0	0.8	0.6	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.7	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.9	0.0	0.1	0.6	0.0	0.7	1.0	1.9	0.8	0.9	0.6	0.9	0.6	0.6	0.6
NCAPD3	"CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056"	ENSG00000151503	"Non-SMC condensin II complex subunit D3"	P42695	11	134150119-134225454	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 82.1"	"Low cell line specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	8	"prostate cancer: 50.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040286			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA040286: AB_2676918"	"unprognostic (4.27e-2)"	"unprognostic (6.05e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.48e-1)"	4.9	6.4	4.9	8.3	7.4	13.7	5.4	8.9	6.2	4.0	5.4	8.5	5.0	5.4	4.7	5.9	7.8	4.2	5.4	4.5	5.5	4.3	4.3	12.1	5.3	7.6	9.0	3.3	4.1	5.9	6.8	9.2	6.0	6.1	82.1	6.1	4.9	6.0	6.6	3.8	9.0	5.6	5.4	6.8	8.5	5.3	14.8	7.1	30.7	6.6	5.3	9.8	4.5	5.4	6.9	11.2	2.6	5.6	5.8	10.4	3.8	13.0	11.6	12.8	19.2	5.2	3.8	8.5	15.4	9.8	14.2	15.7	22.7	20.6	24.3	20.7	7.9	21.8	23.8	13.3	15.5	21.9	20.7	41.6	11.7	10.0	2.4	25.7	22.6	2.6	2.2	18.8	6.1	9.2	22.1	14.4	10.6	10.9	29.6	16.7	8.7	20.6	17.4	15.1	14.0	5.5	16.8	25.6	12.0	22.4	17.9	3.6	28.3	14.8	7.4	18.4	7.8	12.5	19.2	6.2	6.2	22.8	5.3	30.7	15.4	1.7	5.6	2.6	9.5	5.0	5.6	3.7	6.4	7.2	5.1	6.9	8.9	10.4	2.2	5.8	4.1	11.2	9.4	3.8	4.9	7.4	8.9	6.2	5.5	4.3	9.0	3.3	6.1	7.1
NLRP9	"CLR19.1, NALP9, NOD6, PAN12"	ENSG00000185792	"NLR family pyrin domain containing 9"	Q7RTR0	19	55708432-55738402	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 5.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;Karpas-707: 1.1;U-266/84: 1.3"	"Cancer enriched"	"Detected in single"	59	"testis cancer: 14.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA042623	Uncertain									"HPA042623: AB_10965692"	"unprognostic (2.50e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.82e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.56e-2)"	"unprognostic (8.09e-3)"	0.1	0.2	0.0	0.2	0.5	0.7	0.1	0.5	0.1	0.1	0.3			0.2	0.4	0.7	0.1	0.4	0.2	0.1	0.0	0.0	1.0	0.9	0.4	0.2	0.0		0.7	0.8	0.1	0.6	0.1		5.3	0.1		0.1	0.2	0.1	0.4	1.2	0.1	0.0	0.9	2.0	1.9			0.2		0.1	0.1	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.9	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	1.3	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0										
OPRK1	"KOR, OPRK"	ENSG00000082556	"Opioid receptor kappa 1"	P41145	8	53225716-53251697	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.0;prostate: 6.7"	"Cell line enriched"	"Detected in some"	5	"U-937: 21.6"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067549	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA067549: AB_2732770"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-2)"		"unprognostic (8.70e-3)"	"unprognostic (3.73e-2)"	"unprognostic (6.74e-2)"		"unprognostic (2.22e-3)"		"unprognostic (8.09e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.28e-3)"		"unprognostic (3.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.54e-4)"	"unprognostic (1.61e-1)"	0.7	0.7	15.9	0.3	18.0	0.4	0.3	2.2	8.8	0.4	0.4	0.3	0.0	0.4	0.4	0.6	0.5	0.7	0.4	0.8	4.5	6.2	0.3	0.5	0.8	0.4	1.7	5.8	0.4	0.3	0.4	0.8	2.8	3.1	6.7	0.4	0.0	0.3	0.4	3.8	0.4	0.5	0.5	0.5	0.6	0.3	2.8	1.6	0.2	0.9	0.0	0.3	0.3	0.1	0.2	0.8	1.2	0.2	0.1	0.4	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	21.6	0.1	1.2	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.0	15.9	18.0	2.2	8.8	4.5	6.2	1.7	5.8	3.1	1.6
OR14C36	OR5BF1	ENSG00000177174	"Olfactory receptor family 14 subfamily C member 36"	Q8NHC7	1	248348775-248349713	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"prostate: 1.7"	"Cell line enriched"	"Detected in single"	23	"HeLa: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.4		0.0	0.0	0.0	0.0	0.0		1.7	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0										
OR2L3		ENSG00000198128	"Olfactory receptor family 2 subfamily L member 3"	Q8NG85	1	248046836-248063407	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.0;prostate: 4.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.8;Karpas-707: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.3	0.2	0.4	1.0	0.4	3.0	0.6	1.3	0.5	0.4	0.0			0.1	0.2	0.1	0.0	0.4	0.3	0.0	0.6	0.8	0.0	0.0	0.1	0.4	0.8		0.0	0.0	0.0	0.9	0.2		4.1	0.0		0.1	0.1	0.0	0.3	0.1	0.0	1.5	0.8	0.0	0.2			0.4		0.0	0.3	0.0	0.1	0.0	0.5	0.2	0.1	0.3	0.0	0.5	0.4	0.8	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.3	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.3	0.0	1.8	0.1	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.7	0.4	0.4	0.5	0.7	0.1	0.8	0.2	0.1	0.5	0.2	0.1	0.4	0.0	0.0	0.1	1.0	0.0	0.8	0.5	0.3	0.4	0.9	0.5	0.7	1.1	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0										
OR2T29		ENSG00000182783	"Olfactory receptor family 2 subfamily T member 29"	Q8NH02	1	248556912-248562772	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.5;kidney: 2.7;prostate: 1.6"	"Cell line enriched"	"Detected in single"	32	"Karpas-707: 3.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	14	"memory B-cell: 1.3;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"B-cells: 1.5"																																					0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0			0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.5	0.0		0.0	0.1	0.0	0.0	0.0		1.6	0.0		0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2			0.3		0.1	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2T4	OR2T4Q	ENSG00000196944	"Olfactory receptor family 2 subfamily T member 4"	Q8NH00	1	248361581-248362627	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 1.0;cervix, uterine: 1.1;prostate: 1.2"	"Cell line enhanced"	"Detected in single"		"BJ hTERT+: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	1.1	0.0			0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.7		0.0	0.0	0.0	0.0	0.0		1.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR51E1	"GPR136, GPR164, OR51E1P, OR52A3P"	ENSG00000180785	"Olfactory receptor family 51 subfamily E member 1"	Q8TCB6	11	4643420-4655488	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"placenta: 10.0;prostate: 12.1"	"Cell line enriched"	"Detected in single"	114	"SCLC-21H: 14.1"	"Cancer enriched"	"Detected in many"	21	"prostate cancer: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB019995, HPA051439"	Approved									"CAB019995: AB_10283600, HPA051439: AB_2681487"	"unprognostic (6.67e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.71e-2)"	"unprognostic (4.87e-5)"	"unprognostic (3.55e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.94e-3)"	"unprognostic (7.36e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavourable (1.23e-6)"	"unprognostic (2.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.86e-1)"	7.6	0.0	0.6	1.9	0.8	0.0	5.1	0.1	0.6	0.9	2.6	0.1	0.1	0.4	2.5	0.3	0.8	0.8	0.7	4.8	0.1	0.2	1.6	0.1	0.1	1.9	0.6	0.1	1.0	0.1	0.2	1.0	10.0	0.6	12.1	1.1	0.8	4.4	0.8	2.4	0.3	2.1	1.3	1.8	0.1	0.9	0.3	0.1	0.1	0.9	0.9	0.4	1.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.1	0.6	0.1	0.2	0.6	0.1	0.6	0.1
OR51E2	PSGR	ENSG00000167332	"Olfactory receptor family 51 subfamily E member 2"	Q9H255	11	4680171-4697854	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"prostate: 42.1;retina: 14.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.2;BJ hTERT+: 3.4"	"Cancer enriched"	"Detected in some"	274	"prostate cancer: 217.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"														"unprognostic (1.98e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (8.00e-4)"	"unprognostic (3.61e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.04e-5)"	"unprognostic (3.34e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.29e-1)"	0.7	0.2	0.2	5.0	0.2	0.1	1.7	0.1	0.5	0.6	8.2	0.0	0.5	0.2	1.6	1.3	0.6	0.6	0.3	1.1	0.2	0.2	0.4	0.1	0.1	0.0	0.2	0.0	1.1	0.2	0.1	0.2	5.1	0.4	42.1	2.2	14.6	0.2	2.4	0.5	0.3	0.9	2.0	0.2	0.1	0.5	0.7	0.0	0.0	0.2	0.4	0.0	1.6	0.3	1.6	0.9	2.2	0.6	0.8	1.2	0.4	0.1	0.0	0.1	0.1	0.7	6.2	0.3	0.0	3.4	0.0	0.2	0.2	0.3	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	1.2	1.2	0.3	0.0	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.5	0.1	0.1	0.4	0.0	0.3	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.0	0.5	0.4	0.7	0.3	0.0	0.5	0.0	0.1	0.4	0.0	0.0	1.5	0.6	0.5	1.2	0.5	0.8	0.8	0.8	0.6	0.3	1.6	0.8	1.1	2.2	0.8	0.5	0.9	0.4	0.4	0.2	0.2	0.1	0.5	0.2	0.2	0.2	0.0	0.4	0.0
OR51T1		ENSG00000176900	"Olfactory receptor family 51 subfamily T member 1"	Q8NGJ9	11	4881819-4882883	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"prostate: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 0.5"	"Low region specificity"	"Detected in some"			HPA046877	Uncertain									"HPA046877: AB_2679853"												"unprognostic (2.59e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0			0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1			0.0		0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0										
OSTN		ENSG00000188729	Osteocrin	P61366	3	191199241-191265615	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 7.8;brain: 7.9;prostate: 8.0"	"Cell line enriched"	"Detected in some"	24	"U-2197: 29.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"memory B-cell: 7.8"	"Lineage enriched"	"Detected in single"	10	"B-cells: 7.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.2"	"Low region specificity"	"Detected in all"			"CAB024997, CAB025649, HPA030878"	Uncertain				"Secreted in other tissues"					"CAB024997: , CAB025649: , HPA030878: AB_2673642"					"unprognostic (2.35e-2)"		"unprognostic (9.12e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.45e-1)"			0.9	0.4	1.9	1.6	2.1	0.0	0.6	0.2	7.9	7.1	0.4	0.0	0.0	0.0	0.2	4.4	0.1	1.9	1.9	1.5	1.8	1.9	0.5	1.6	1.0	1.3	1.5	2.4	0.5	0.1	0.0	0.3	1.1	0.4	8.0	0.1	0.0	0.4	0.2	2.3	3.4	0.3	2.3	1.1	0.5	0.6	1.1	0.0	0.0	0.6	0.7	0.0	3.7	1.0	7.8	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	1.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	1.9	2.1	0.2	7.9	1.8	1.9	1.5	2.4	0.4	0.0
P2RX2	"DFNA41, P2X2"	ENSG00000187848	"Purinergic receptor P2X 2"	Q9UBL9	12	132618776-132622386	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 23.1;prostate: 11.1;seminal vesicle: 16.1"	"Group enriched"	"Detected in some"	4	"MCF7: 6.6;T-47d: 15.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"amygdala: 6.1;hippocampal formation: 8.6"	"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.12e-1)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.79e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-1)"		"unprognostic (9.12e-2)"	0.4	0.1	6.1	0.5	0.6	0.0	0.3	0.3	1.6	0.7	1.5	0.3	3.0	1.1	0.3	23.1	5.3	2.5	0.3	0.3	8.6	0.9	1.1	0.3	3.6	1.8	0.3	0.3	0.3	0.3	0.0	0.9	0.7	0.3	11.1	0.3	0.6	0.3	16.1	0.3	0.0	3.4	0.3	0.3	2.4	1.3	1.3	0.3	0.3	0.3	0.3	0.8	0.7	1.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	6.6	0.1	0.4	0.7	0.0	0.1	0.2	0.1	0.0	0.4	0.1	0.0	0.0	2.6	0.0	15.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.2	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.1	0.6	0.3	1.6	8.6	0.9	0.3	0.3	0.3	0.3
PABPC1L2A	RBM32A	ENSG00000186288	"Poly(A) binding protein cytoplasmic 1 like 2A"	Q5JQF8	X	73077276-73079512	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.6;prostate: 5.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 8.9;NTERA-2: 3.3;SK-MEL-30: 1.8"	"Cancer enriched"	"Detected in single"	15	"prostate cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041573	Approved									"HPA041573: AB_2677556"					"unprognostic (4.30e-2)"							"unprognostic (2.19e-1)"			"unprognostic (3.22e-1)"			0.1	3.5	3.3	0.2	5.0	0.0	0.1	7.1	9.6	0.1	0.2			0.4	0.1	1.4	0.0	0.2	0.2	0.0	3.5	9.2	0.2	0.1	0.1	0.0	2.9		0.4	0.1	0.0	1.2	0.0		5.2	0.1		0.8	0.6	0.1	0.1	0.2	0.0	2.4	0.7	0.1	3.2			0.3		0.1	0.2	0.0	0.2	0.1	0.7	0.2	0.8	0.1	0.3	0.0	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.1	0.1	0.9	0.1	0.0	0.0	0.0	0.0	8.9	0.4	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.4	0.1	1.8	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.3	0.1	0.5	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.8	0.2	0.1	0.0	0.3										
PAK1IP1	"bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84"	ENSG00000111845	"PAK1 interacting protein 1"	Q9NWT1	6	10694695-10709782	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 48.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030111, HPA030112"	Supported		Supported	Nucleoli				Nucleoli	Nucleoli	"HPA030111: AB_2732454, HPA030112: AB_10603125"	"unprognostic (9.41e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (1.35e-6)"	"unprognostic (7.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (7.02e-8)"	"unprognostic (8.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-1)"	12.8	9.9	12.0	12.2	9.7	11.5	15.9	9.1	15.7	12.7	8.7	5.8	7.7	5.9	10.5	9.9	15.7	8.7	7.2	8.6	9.2	9.8	12.3	17.5	7.2	16.3	10.9	9.2	13.8	10.6	6.8	9.1	9.1	11.3	48.8	9.8	4.2	10.3	10.4	20.6	7.8	6.8	10.5	10.1	10.9	7.4	6.3	9.9	8.4	9.3	18.5	11.7	8.2	9.1	8.4	11.5	2.4	10.3	8.1	12.3	5.8	14.1	5.6	7.3	12.5	9.1	8.3	10.5	9.3	7.7	14.1	13.9	12.3	6.4	14.4	23.4	7.9	7.6	14.9	12.0	20.4	8.4	10.0	7.9	5.2	14.1	13.3	21.8	10.4	7.7	10.5	13.7	23.4	9.4	23.8	4.2	11.7	8.4	10.9	20.1	15.8	10.0	11.3	9.5	22.3	10.2	8.5	11.0	9.5	6.9	17.9	19.9	7.9	8.0	8.1	11.5	8.3	12.3	23.0	9.9	27.0	15.8	4.7	14.7	21.5	1.1	7.1	2.4	8.4	10.3	8.6	8.4	7.6	8.4	10.0	6.4	10.2	12.3	0.3	8.1	8.0	11.5	4.8	5.8	12.0	9.7	9.1	15.7	9.2	9.8	10.9	9.2	11.3	9.9
PDE11A		ENSG00000128655	"Phosphodiesterase 11A"	Q9HCR9	2	177623252-178072755	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 20.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.7;fHDF/TERT166: 5.5;HAP1: 3.1;Hep G2: 6.2"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA034560	Approved				"Intracellular and membrane"					"HPA034560: AB_10602140"	"unprognostic (1.02e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-4)"	"unprognostic (1.64e-3)"	2.9	0.5	1.3	0.7	1.0	0.2	2.5	0.2	0.8	4.2	3.1	0.1	0.0	1.2	1.9	1.5	0.3	0.4	5.4	2.6	1.6	2.0	4.0	11.8	0.5	0.0	3.3	0.0	0.5	7.8	9.8	13.6	0.0	1.2	20.8	0.5	5.6	8.5	1.2	7.5	0.3	7.6	1.7	5.6	0.1	0.4	3.8	0.0	0.1	13.2	0.7	0.1	0.6	0.3	1.0	0.8	2.2	0.9	0.9	0.7	0.2	0.1	1.0	0.5	0.2	0.2	0.0	0.2	2.5	0.4	0.1	0.8	0.5	3.7	0.1	1.5	5.5	0.2	3.1	0.1	0.1	0.0	2.0	2.4	0.2	6.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.9	0.3	1.2	0.1	0.5	0.1	0.5	0.0	1.1	0.1	0.7	1.7	0.0	0.2	0.4	0.3	0.0	0.0	0.3	0.6	0.2	0.3	0.5	0.0	0.0	1.0	0.1	0.2	1.6	0.7	1.1	0.7	0.6	0.5	0.7	0.6	0.7	0.4	1.0	0.6	0.7	2.2	0.9	0.9	0.8	0.7	0.2	1.3	1.0	0.2	0.7	1.6	2.0	3.3	0.0	1.2	0.0
PMEPA1	"STAG1, TMEPAI"	ENSG00000124225	"Prostate transmembrane protein, androgen induced 1"	Q969W9	20	57648392-57711536	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 60.4;prostate: 67.3"	"Cell line enhanced"	"Detected in many"		"SiHa: 39.5;U-2 OS: 25.8;U-251 MG: 90.8;WM-115: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"naive B-cell: 5.2;plasmacytoid DC: 18.4"	"Group enriched"	"Detected in many"	7	"B-cells: 5.2;dendritic cells: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072291			Supported	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA072291: AB_2686509"	"unprognostic (2.72e-3)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (5.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.11e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (4.73e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (7.83e-3)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (2.87e-7)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.87e-3)"	"prognostic unfavourable (7.60e-4)"	27.0	7.8	7.5	10.6	34.8	1.3	9.5	2.6	12.6	60.4	10.8	11.0	4.2	4.4	22.1	6.7	7.1	7.7	21.8	10.7	7.5	8.6	5.3	1.7	8.5	4.5	10.2	5.9	6.2	18.6	2.6	5.6	3.0	12.1	67.3	5.7	21.3	11.6	13.3	17.4	6.8	7.6	17.6	8.1	4.0	5.3	3.2	9.1	1.3	5.4	6.0	6.2	8.4	13.0	5.2	18.4	0.1	0.3	0.0	1.6	0.4	5.9	14.5	0.4	0.7	0.4	0.0	0.1	0.9	0.0	0.3	0.1	0.2	18.8	0.0	3.5	1.4	23.0	0.3	19.4	0.2	0.1	0.7	0.0	4.0	0.0	0.3	0.0	0.1	0.2	10.9	0.8	2.4	2.5	0.1	0.2	1.2	12.3	0.7	0.1	1.8	1.8	0.0	7.0	2.1	4.7	0.0	3.4	2.7	39.5	23.5	2.7	3.6	0.7	6.3	3.5	25.8	0.3	90.8	1.1	0.1	0.0	1.6	0.2	45.8	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.6	0.2	0.0	5.2	1.6	0.9	0.1	0.0	0.0	18.4	0.4	0.4	7.5	34.8	2.6	12.6	7.5	8.6	10.2	5.9	12.1	9.1
POTEJ	POTE2beta	ENSG00000222038	"POTE ankyrin domain family member J"	P0CG39	2	130611481-130658091	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 2.6;testis: 3.4"	"Cell line enriched"	"Detected in single"	8	"RPMI-8226: 3.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041264, HPA041271, HPA043260"	Uncertain					1700000000	1700000000			"HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396"	"unprognostic (8.11e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.07e-2)"		"unprognostic (5.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.30e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.2	0.0		2.6	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	3.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRDM8	KMT8D	ENSG00000152784	"PR/SET domain 8"	Q9NQV8	4	80183879-80204329	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0;prostate: 30.9;seminal vesicle: 34.0"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 17.9;NB-4: 20.1;SCLC-21H: 43.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 31.4"	"Group enriched"	"Detected in many"	4	"amygdala: 15.7;cerebral cortex: 21.5;hippocampal formation: 24.7"	HPA057253			Approved	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA057253: AB_2683382"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-11)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-1)"	3.6	3.5	17.6	6.3	10.1	4.4	3.3	3.6	31.0	9.3	8.2	10.9	1.8	2.1	8.2	3.0	2.8	3.7	2.7	1.9	30.9	6.0	1.4	0.9	2.0	6.1	12.3	18.1	5.5	1.1	0.8	4.5	5.6	7.5	30.9	2.6	4.3	1.5	34.0	3.0	2.1	4.4	8.6	15.2	2.5	4.4	1.9	9.0	0.0	1.1	0.0	3.5	9.0	8.2	2.2	0.5	2.1	0.0	0.7	2.4	0.4	0.9	0.0	0.3	0.0	0.9	3.2	0.0	2.4	8.8	1.2	1.4	0.0	0.9	0.0	0.0	3.0	0.3	0.0	1.0	5.3	3.7	0.8	0.3	0.0	0.0	1.8	3.7	1.1	2.0	0.0	4.8	1.4	0.1	0.0	1.6	17.9	0.0	1.7	20.1	0.0	7.3	0.6	0.0	0.0	0.5	0.1	43.4	6.0	0.1	0.0	0.0	0.0	1.9	3.7	3.1	0.4	2.3	0.1	0.7	0.0	0.0	7.8	1.7	0.4	0.0	0.0	0.0	1.6	0.0	2.4	0.3	2.1	2.0	0.3	2.2	1.3	0.7	2.1	0.7	0.0	0.5	0.9	0.4	17.6	10.1	3.6	31.0	30.9	6.0	12.3	18.1	7.5	9.0
PRIM2	PRIM2A	ENSG00000146143	"DNA primase subunit 2"	P49643	6	57314805-57646849	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 21.7;prostate: 22.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046566			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA046566: AB_2679701"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-2)"	"prognostic unfavourable (3.44e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (3.00e-5)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (3.89e-1)"	"prognostic unfavourable (7.34e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	5.4	1.6	1.7	9.0	2.3	7.8	4.1	6.5	3.3	5.3	3.9	2.5	2.4	3.0	9.7	3.7	5.6	3.7	2.7	3.1	2.8		3.5	2.7	2.7	7.1	3.6	1.5	4.3	2.2	2.4	5.4	5.9	1.7	22.6	5.0	3.5	7.3	3.4	1.1	3.4	3.7	5.8	3.6	6.7	2.4	5.3	3.1	21.7	4.6	4.5	8.7	4.7	2.7	5.0	7.3	2.5	5.4	5.6	7.9	2.7	15.1	6.2	12.4	14.3	7.1	12.5	10.3	18.7	18.3	20.9	28.1	9.8	7.3	13.9	10.4	23.3	10.3	11.1	10.7	25.9	15.1	9.0	16.4	8.5	16.4	2.9	15.8	10.4	4.7	4.0	23.0	8.1	9.4	15.5	36.9	17.4	9.6	16.5	12.5	7.8	6.1	12.6	17.1	11.0	7.6	7.9	9.2	6.9	12.1	5.8	7.6	12.4	13.7	6.5	21.3	21.0	39.0	15.8	5.0	9.6	16.1	9.7	16.7	11.4	0.3	2.4	2.5	5.5	5.1	6.2	5.0	5.0	7.5	4.1	4.9	3.6	7.9	1.0	5.6	5.4	7.3	5.9	2.7										
RAB3B		ENSG00000169213	"RAB3B, member RAS oncogene family"	P20337	1	51907956-51990764	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2;placenta: 37.6;prostate: 20.0"	"Cell line enhanced"	"Detected in many"		"BJ: 43.7;BJ hTERT+: 16.9;fHDF/TERT166: 15.8;TIME: 33.9"	"Group enriched"	"Detected in many"	6	"prostate cancer: 19.4;testis cancer: 6.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003159, CAB023293"	Enhanced		Approved	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"CAB023293: , HPA003159: AB_1856005"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	0.4	5.8	16.6	1.4	8.5	0.8	1.8	2.0	13.8	0.4	3.1	0.9	0.0	1.6	0.5	0.8	0.5	0.7	2.7	0.4	9.9	15.8	1.4	1.3	0.5	0.5	4.5	9.3	3.2	2.1	0.4	13.7	37.6	18.2	20.0	4.4	0.1	0.8	0.6	1.0	3.7	1.9	0.9	1.4	0.5	2.7	0.8	1.3	0.0	0.5	0.0	0.6	0.6	0.4	1.1	0.8	2.1	0.5	0.5	0.4	0.0	0.6	2.9	0.4	0.4	0.1	0.8	0.0	43.7	16.9	8.8	4.3	3.5	1.3	0.2	0.7	15.8	0.0	5.4	4.5	15.0	0.0	0.4	0.0	0.2	1.1	0.7	0.0	0.0	0.4	0.1	14.6	3.3	2.7	0.1	0.1	9.7	0.1	0.0	0.0	7.0	0.4	0.1	0.0	0.0	1.4	0.2	1.5	0.4	0.0	0.1	0.0	0.0	0.1	33.9	8.6	3.2	0.1	14.2	0.0	0.2	0.1	7.8	0.0	0.3	1.1	0.5	0.3	0.4	0.3	0.3	0.6	0.3	0.4	0.1	1.1	0.4	0.4	2.1	0.5	0.5	0.8	0.2	0.0	16.6	8.5	2.0	13.8	9.9	15.8	4.5	9.3	18.2	1.3
RDH11	"ARSDR1, MDT1, SDR7C1"	ENSG00000072042	"Retinol dehydrogenase 11 (all-trans/9-cis/11-cis)"	Q8TC12	14	67676801-67695814	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 204.2"	"Low cell line specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	13	"prostate cancer: 286.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046011	Enhanced				"Intracellular and membrane"	9100000	9100000			"CAB046011: AB_11129613"	"unprognostic (1.38e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.77e-1)"	"prognostic favourable (2.62e-4)"	"unprognostic (6.06e-2)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (9.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (1.30e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.74e-2)"	8.8	24.9	18.3	8.9	19.0	5.1	10.8	15.7	25.3	13.0	10.8	24.3	16.1	12.3	13.0	31.4	13.6	9.3	15.6	7.2	18.5	19.9	40.7	51.6	12.6	7.2	21.8	16.6	11.4	15.3	28.7	13.1	8.3	31.1	204.2	12.0	40.4	16.2	13.5	3.6	11.2	10.2	15.8	32.5	10.8	11.6	10.3	15.8	12.5	24.2	8.1	9.5	14.8	11.4	11.5	17.0	62.4	19.7	14.4	20.8	28.2	46.9	21.4	19.0	21.6	30.5	27.7	15.9	17.9	35.4	22.5	40.9	17.8	57.2	8.1	13.9	16.8	37.7	27.4	39.5	30.7	16.4	11.1	16.9	11.4	17.6	29.3	6.2	12.4	25.8	26.2	29.2	24.9	25.6	13.2	27.0	20.4	24.9	18.2	9.7	10.7	24.6	13.8	23.6	11.7	51.4	24.2	19.8	16.6	18.8	23.9	24.9	26.7	9.9	19.7	24.2	27.7	10.4	12.8	12.8	10.1	10.6	31.5	17.3	19.6	62.4	19.7	28.2	18.7	16.1	20.4	11.3	20.5	18.5	14.5	11.5	20.8	20.1	3.3	14.4	16.9	17.0	17.6	28.2	18.3	19.0	15.7	25.3	18.5	19.9	21.8	16.6	31.1	15.8
RPS4Y2	RPS4Y2P	ENSG00000280969	"Ribosomal protein S4, Y-linked 2"	Q8TD47	Y	20756164-20781032	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 10.7;prostate: 6.8;salivary gland: 3.8;testis: 3.3"	"Cell line enriched"	"Detected in single"	7	"U-266/84: 6.3"	"Cancer enriched"	"Detected in single"	9	"prostate cancer: 1.8"					"Cell type enriched"	"Detected in some"	5	"neutrophil: 10.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.7"									HPA000857	Uncertain									"HPA000857: AB_1079849"					"unprognostic (1.50e-2)"							"unprognostic (3.63e-1)"		"unprognostic (6.39e-6)"	"unprognostic (5.92e-2)"			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	10.7	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	2.2	0.1	0.0	10.7	0.0	0.0	0.0	0.0	0.0										
SLC30A4	ZNT4	ENSG00000104154	"Solute carrier family 30 member 4"	O14863	15	45479611-45522807	"Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 47.7"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	20	"prostate cancer: 34.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018178	Uncertain									"HPA018178: AB_1857087"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.51e-1)"	"prognostic favourable (6.02e-4)"	"unprognostic (2.66e-2)"	"unprognostic (4.72e-3)"	"unprognostic (1.29e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.28e-3)"	"unprognostic (2.01e-3)"	3.7	2.9	6.2	4.5	11.3	1.6	4.1	6.7	8.1	3.7	8.8	7.0	2.3	8.5	4.3	4.1	5.6	3.4	3.1	3.0	5.2	3.8	5.5	3.6	2.9	3.6	6.9	4.9	3.9	2.8	6.8	3.0	4.6	5.1	47.7	4.4	3.1	2.7	3.5	2.4	3.6	19.9	4.7	4.5	4.0	3.0	15.8	9.0	1.0	6.2	1.8	4.5	3.1	4.4	7.1	0.5	2.6	0.3	2.4	4.3	1.0	2.0	2.5	0.7	5.5	10.1	7.1	0.5	5.3	4.8	3.3	4.6	0.3	1.8	7.9	1.8	5.4	1.5	2.3	2.5	3.0	1.9	2.2	0.2	2.5	0.2	6.5	0.2	4.2	6.0	4.0	4.3	1.1	3.7	1.1	4.5	6.0	0.9	2.7	0.4	0.2	0.5	4.1	4.7	1.2	2.6	0.5	1.8	2.7	3.5	4.0	0.9	3.5	0.3	7.0	4.9	2.8	5.8	1.8	8.5	6.1	2.0	2.1	0.3	3.6	2.6	0.3	0.3	4.3	0.2	3.9	3.8	2.9	2.4	0.3	7.1	2.9	4.2	1.1	2.4	0.3	0.5	0.4	1.0	6.2	11.3	6.7	8.1	5.2	3.8	6.9	4.9	5.1	9.0
SLITRK6	FLJ22774	ENSG00000184564	"SLIT and NTRK like family member 6"	Q9H5Y7	13	85792787-85806683	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 13.3;RT4: 45.6;WM-115: 10.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 21.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.1;cerebellum: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"thalamus: 24.7"	"Low region specificity"	"Detected in many"			"HPA014491, HPA014513"	Uncertain		Supported	"Plasma membrane"		9500	9500	"Plasma membrane"	"Plasma membrane"	"HPA014491: AB_10601603, HPA014513: AB_2669026"	"unprognostic (6.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavourable (8.52e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.82e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.51e-2)"	0.4	0.3	0.3	2.7	11.1	0.0	2.9	4.9	0.3	1.0	4.5	0.0	0.2	2.8	0.7	3.4	3.6	0.3	1.1	1.9	0.3	1.3	0.3	1.1	3.1	0.0	0.6	0.0	0.3	0.4	0.0	0.4	4.1	0.8	24.2	5.8	1.7	22.8	1.8	0.3	4.5	7.2	22.4	0.4	0.2	1.2	0.5	1.8	0.0	0.6	3.4	0.7	27.8	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.2	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	13.3	0.0	1.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	45.6	0.4	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.1	4.9	0.3	0.3	1.3	0.6	0.0	0.8	1.8
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572882-100663415	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0"	"Cell line enriched"	"Detected in single"	50	"RT4: 41.9"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"thalamus: 2.9"	"Group enriched"	"Detected in some"	4	"basal ganglia: 0.8;olfactory region: 3.1"	"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA024284: AB_1853894, HPA053466: AB_2682161"	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favourable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.5	0.0	0.6	0.1	0.7	0.1	0.4	0.6	2.3	1.7	0.3	0.3	0.1	0.2	0.3	0.2	6.2	0.3	0.9	1.8	0.8	0.7	0.3	0.4	0.3	0.3	0.9	0.3	0.3	0.2	0.1	0.2	0.1	0.6	13.8	0.1	0.4	1.4	0.1	1.0	0.5	0.1	7.4	0.8	0.1	0.6	3.3	0.5	0.1	0.4	2.6	21.4	25.4	16.0	1.1	0.3	3.0	0.5	1.6	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	41.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	2.5	0.5	0.2	0.3	0.2	0.1	1.1	0.1	0.2	0.2	0.5	0.1	0.3	3.0	1.6	0.0	0.3	0.0	0.0	0.6	0.7	0.6	0.3	0.8	0.7	0.9	0.3	0.6	0.5
SOX14	SOX28	ENSG00000168875	"SRY-box 14"	O95416	3	137764284-137766338	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.4;placenta: 15.1;prostate: 3.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"prostate cancer: 2.8"	"Group enriched"	"Detected in many"	15	"hypothalamus: 5.4;midbrain: 1.6;pons and medulla: 4.4;thalamus: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hypothalamus: 2.1;midbrain: 5.9"	"Group enriched"	"Detected in some"	7	"midbrain: 10.3;pons and medulla: 5.6;thalamus: 16.5"														"unprognostic (1.43e-1)"	"unprognostic (1.63e-1)"								"unprognostic (1.88e-2)"		"unprognostic (2.49e-3)"	"unprognostic (5.08e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	15.1	4.4	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	5.4	1.6	0.0	4.4	3.3
SPDEF	"bA375E1.3, PDEF"	ENSG00000124664	"SAM pointed domain containing ETS transcription factor"	O95238	6	34537802-34556333	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 55.8;salivary gland: 98.0"	"Group enriched"	"Detected in some"	5	"MCF7: 68.4;SK-BR-3: 47.3;T-47d: 37.8"	"Group enriched"	"Detected in many"	10	"breast cancer: 103.4;endometrial cancer: 78.1;prostate cancer: 388.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"midbrain: 2.1"	HPA055707			Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA055707: AB_2682894"	"unprognostic (2.98e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (9.26e-9)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-1)"	"unprognostic (6.16e-11)"	"unprognostic (8.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.4	2.4	0.2	0.0	28.5	0.3	0.7	12.0	6.5	0.2	0.3	4.4	4.0	0.3	0.9	2.4	16.1	0.1	0.4	0.3	0.1	0.1	5.5	0.1	0.3	0.1	0.6	1.3	0.0	0.1	0.2	0.1	55.8	4.0	0.2	98.0	4.5	0.1	3.0	7.8	0.1	0.1	0.1	10.8	0.1	0.1	0.2	0.1	7.8	22.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.1	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	47.3	0.0	37.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.7	0.4	0.3	0.3	0.1	0.1	0.1
SRD5A2		ENSG00000277893	"Steroid 5 alpha-reductase 2"	P31213	2	31522480-31581067	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 17.9;liver: 30.9;prostate: 28.4"	"Group enriched"	"Detected in some"	7	"BJ hTERT+: 2.8;RT4: 5.4"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (6.75e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.92e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-3)"	"unprognostic (6.61e-6)"	"unprognostic (4.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.48e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	10.1	0.0	0.2	17.9	0.0	10.4	0.0	0.0	0.0		0.0	30.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0										
STEAP1	"PRSS24, STEAP"	ENSG00000164647	"STEAP family member 1"	Q9UHE8	7	90154375-90164829	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 44.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.1;CAPAN-2: 34.8;U-138 MG: 44.3"	"Cancer enriched"	"Detected in all"	6	"prostate cancer: 94.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.7"	"Low lineage specificity"	"Detected in single"											HPA030985	Uncertain									"HPA030985: AB_2673686"	"unprognostic (2.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.21e-3)"	"unprognostic (9.20e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.74e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.45e-3)"	"unprognostic (8.31e-3)"	"unprognostic (3.79e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.38e-1)"	19.8	1.5	2.9	16.5	1.4	0.0	26.0	0.9	6.3	5.5	10.0	0.1	0.7	2.7	3.0	4.4	10.0	7.3	8.4	7.1	1.4	0.5	5.3	21.2	9.3	2.9	0.5	2.7	12.4	6.5	0.2	5.8	0.5	1.4	44.7	7.3	1.2	9.8	5.3	3.9	3.3	7.4	13.7	1.4	2.8	7.4	2.1	0.7	0.0	4.6	6.5	3.7	12.5	16.1	0.8	1.7	0.0	0.0	0.0	0.0	0.2	6.7	13.6	0.8	2.5	29.1	24.2	0.2	4.6	5.7	0.6	0.8	10.2	34.8	0.0	0.2	7.5	1.4	5.9	6.4	1.2	0.0	2.2	0.0	0.1	3.4	1.1	0.0	0.0	17.0	0.9	19.2	10.2	25.0	0.3	19.4	7.9	0.1	0.0	0.1	4.1	6.5	0.0	0.0	0.0	5.5	1.4	0.0	0.3	1.7	0.0	3.1	7.7	0.1	12.8	44.3	2.2	22.2	5.6	3.6	0.1	0.0	21.7	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	1.4	0.9	6.3	1.4	0.5	0.5	2.7	1.4	0.7
SYT7	"IPCA-7, MGC150517, PCANAP7, SYT-VII"	ENSG00000011347	"Synaptotagmin 7"	O43581	11	61515313-61581148	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.4;prostate: 36.9;salivary gland: 37.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 15.0;hTERT-HME1: 39.3;RT4: 16.0;SCLC-21H: 12.7;SK-BR-3: 17.9;T-47d: 17.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 54.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012869	Enhanced									"HPA012869: AB_1857698"	"unprognostic (7.09e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.42e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (4.37e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.47e-1)"	2.5	3.7	16.2	1.4	22.7	0.6	6.9	22.8	46.4	2.8	4.0	3.2	0.0	2.1	2.0	1.9	1.9	1.7	1.4	11.1	11.8	7.8	4.4	28.2	1.7	0.8	4.9	23.6	1.2	11.9	2.2	22.2	12.7	8.8	36.9	4.2	2.4	37.7	1.3	2.8	1.6	3.3	1.8	1.5	1.8	3.4	2.5	3.0	0.0	3.5	0.6	0.8	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.6	0.8	0.2	0.0	0.4	6.4	4.6	0.1	15.0	0.2	0.2	1.4	3.0	0.0	0.2	0.0	3.0	0.4	0.1	0.1	0.1	0.7	0.0	0.6	0.8	0.4	0.0	0.0	0.2	3.5	1.8	39.3	0.0	0.0	0.1	0.2	9.3	0.0	0.1	1.0	6.3	0.0	0.3	0.7	0.0	16.0	12.7	2.3	0.8	17.9	0.1	17.5	0.0	0.0	3.7	1.4	4.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	22.7	22.8	37.5	11.8	7.8	4.9	23.6	8.8	3.0
TBX20		ENSG00000164532	"T-box 20"	Q9UMR3	7	35202430-35254147	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 26.5;heart muscle: 46.4;prostate: 24.2;smooth muscle: 47.0;urinary bladder: 32.3"	"Cell line enhanced"	"Detected in some"		"HHSteC: 4.7;HMC-1: 5.3;RH-30: 5.2;SH-SY5Y: 9.9;WM-115: 5.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (2.20e-1)"		"unprognostic (1.25e-2)"	"unprognostic (1.87e-2)"				"unprognostic (8.47e-2)"		"unprognostic (3.95e-2)"				"unprognostic (2.75e-1)"	"unprognostic (1.74e-1)"		"unprognostic (9.75e-2)"	0.2	4.3	0.2	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.2	0.2	26.5	46.4	0.2	0.2	0.2	0.6	0.2	0.1	0.2	0.0	0.2	0.2	0.1	1.8	15.1	0.0	24.2	0.1	2.7	0.2	0.1	0.2	0.2	0.2	47.0	0.2	0.2	0.2	0.4	0.0	0.0	0.2	0.0	0.1	32.3	14.4	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	3.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.2	3.1	0.0	0.6	0.0	0.3	4.2	0.0	0.1	2.2	3.4	4.2	1.4	0.0	4.7	0.0	5.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	5.2	0.0	0.1	0.0	0.2	9.9	0.5	0.0	0.0	0.0	3.7	0.0	0.0	0.2	3.6	0.0	0.4	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TMEFF2	"CT120.2, HPP1, TENB2, TPEF, TR"	ENSG00000144339	"Transmembrane protein with EGF like and two follistatin like domains 2"	Q9UIK5	2	191949043-192195709	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6;prostate: 46.3;seminal vesicle: 17.5"	"Group enriched"	"Detected in some"	4	"AF22: 16.9;LHCN-M2: 48.4"	"Cancer enriched"	"Detected in some"	21	"prostate cancer: 57.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015587	Approved				"Secreted in male reproductive system"					"HPA015587: AB_1858069"	"unprognostic (2.12e-3)"	"unprognostic (5.37e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.89e-7)"	"unprognostic (4.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.79e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-1)"	1.1	3.8	20.2	1.1	14.7	1.0	1.1	7.4	29.6	1.1	2.0	18.4	1.7	1.7	1.0	11.1	2.4	1.1	3.0	1.4	17.7	18.5	1.0	1.0	1.1	1.0	15.7	17.7	1.1	1.1	1.1	0.4	1.0	11.1	46.3	2.8	2.8	1.1	17.5	1.3	1.1	1.7	1.1	11.1	1.1	1.4	1.8	15.9	0.0	1.1	0.0	1.2	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	16.9	0.0	2.6	2.7	0.0	0.0	0.3	0.8	1.0	0.0	0.0	0.0	0.0	4.6	0.0	1.0	0.0	3.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	7.3	0.0	0.9	5.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0	1.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.2	0.0	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	14.7	7.4	22.7	17.7	18.5	15.7	17.7	11.1	15.9
TMEM121B	CECR6	ENSG00000183307	"Transmembrane protein 121B"	Q9BXQ6	22	17116299-17121367	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.1;prostate: 14.1"	"Cell line enhanced"	"Detected in some"		"AF22: 6.2;SCLC-21H: 14.7;THP-1: 11.8;U-937: 9.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.3;monocytes: 3.2"	"Group enriched"	"Detected in many"	8	"amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0"	"Low region specificity"	"Detected in many"			HPA068790	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				Vesicles	Vesicles	"HPA068790: AB_2686036"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.49e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.12e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.88e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.10e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.71e-1)"	1.3	1.8	7.4	2.2	12.0	2.2	2.0	8.1	19.1	1.0	0.8	2.4	0.0	1.1	1.1	2.3	0.8	1.2	1.0	2.3	7.1	4.0	0.8	0.8	0.9	0.8	2.9	6.9	0.9	2.7	0.8	2.0	1.9	2.3	14.1	1.0	0.2	1.2	1.0	2.8	1.5	0.9	1.3	2.5	1.1	1.0	2.4	4.2	0.0	0.6	0.0	0.8	1.0	0.3	0.0	0.5	4.3	3.2	0.0	0.0	0.6	0.0	0.0	6.2	0.8	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.8	3.1	2.2	0.1	0.2	3.0	0.0	0.3	0.1	14.7	2.2	0.0	0.0	0.3	0.0	11.8	0.6	0.7	0.3	0.2	0.0	0.2	0.3	0.9	0.0	9.8	0.3	0.0	3.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.6	7.4	12.0	8.1	18.0	7.1	4.0	2.9	6.9	2.3	4.2
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464551-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 75.6;pancreas: 64.5;prostate: 68.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.6;MCF7: 6.3;RT4: 35.2;SK-BR-3: 7.2;T-47d: 5.4"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA034493, HPA035787"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"			"Cell Junctions"	"Cell Junctions"	"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favourable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favourable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.2	0.1	0.2	15.5	0.4	0.0	6.1	0.2	0.5	1.3	38.7	0.4	24.4	17.5	0.5	0.9	10.7	2.2	17.3	0.2	0.3	0.1	19.4	18.4	20.7	0.2	0.2	0.2	0.7	64.5	0.0	1.3	1.0	0.4	68.2	18.5	0.3	52.3	35.7	0.2	2.1	75.6	0.9	0.2	0.3	36.7	0.8	0.3	0.5	19.9	3.9	10.2	5.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	14.6	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.5	1.3	0.0	0.0	0.0	1.4	0.6	35.2	0.0	0.4	0.0	7.2	0.1	5.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	0.2	0.5	0.3	0.1	0.2	0.2	0.4	0.3
TMSB15A	"TMSL8, TMSNB"	ENSG00000158164	"Thymosin beta 15a"	P0CG34	X	102513676-102516784	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.1;prostate: 17.3"	"Cell line enhanced"	"Detected in some"		"AF22: 98.8;NTERA-2: 25.5;RH-30: 44.9;SH-SY5Y: 25.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 56.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"NK-cell: 2.5;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 1.1;NK-cells: 2.5"																				"unprognostic (5.33e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.96e-4)"	"unprognostic (2.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.07e-1)"	1.6	1.0	1.9	1.0	2.2	0.7	5.1	3.4	2.6	4.9	0.8	0.7	2.7	0.3	5.4	1.3	0.9	1.4	1.5	2.2	1.9	1.4	2.7	0.2	16.1	3.8	1.6	0.7	6.1	0.8	0.0	1.0	1.8	1.9	17.3	1.0	0.7	4.0	1.6	1.2	0.5	0.7	2.3	1.7	0.6	0.5	4.7	1.8	7.8	6.1	0.9	2.6	0.9	6.0	0.1	1.1	0.0	0.0	2.5	0.1	1.1	0.0	0.0	98.8	18.4	0.4	0.0	0.0	2.1	0.1	0.2	0.8	0.0	0.1	0.0	0.2	0.3	0.0	18.5	0.1	0.2	0.0	0.9	1.7	0.3	0.0	0.0	0.0	1.7	0.2	0.0	0.1	0.0	1.1	0.1	0.0	6.9	0.0	18.5	0.0	25.5	0.2	0.0	44.9	0.0	1.9	0.0	16.9	25.7	2.3	0.1	0.0	0.2	0.5	0.4	0.0	11.1	0.2	1.7	2.0	0.3	0.0	1.1	0.0	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	1.1	0.0	1.1	1.9	2.2	3.4	2.2	1.9	1.4	1.6	0.7	1.9	1.8
TTC6	"C14orf25, NCRNA00291"	ENSG00000139865	"Tetratricopeptide repeat domain 6"	Q86TZ1	14	37595847-38041442	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 9.7;prostate: 20.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.2;MCF7: 10.5;RT4: 7.3;T-47d: 20.2"	"Group enriched"	"Detected in some"	7	"breast cancer: 2.2;prostate cancer: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA069293			Approved	Centrosome				Centrosome	Centrosome	"HPA069293: AB_2686110"	"unprognostic (7.92e-2)"	"unprognostic (6.95e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.98e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.60e-4)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-4)"	"unprognostic (5.60e-2)"	"unprognostic (8.91e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.07e-3)"	0.0	0.0	0.3	1.3	0.6	0.0	9.7	0.3	0.6	0.2	2.2	0.2	0.0	0.6	0.0	1.3	0.6	0.4	1.0	0.0	0.8	0.9	0.0	7.9	5.6	0.0	0.7	0.4	0.4	0.0	0.0	1.1	0.3	0.1	20.5	0.5	0.0	3.0	1.1	0.0	0.8	1.2	2.5	0.6	0.0	3.8	6.0	0.0	0.0	0.0	0.6	2.3	2.2	4.6	0.6	0.2	0.4	0.0	0.0	0.1	0.0	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.4	0.0	2.1	1.2	0.2	0.0	0.0	3.0	0.0	0.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.5	0.0	0.0	0.0	4.0	0.0	0.0	0.0	1.0	7.3	2.2	0.0	0.0	4.0	0.0	20.2	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.3	0.6	0.8	0.9	0.7	0.4	0.1	0.0
UNC5D	"KIAA1777, Unc5h4"	ENSG00000156687	"Unc-5 netrin receptor D"	Q6UXZ4	8	35235457-35796550	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.4;intestine: 11.7;pituitary gland: 14.2;prostate: 10.6"	"Group enriched"	"Detected in some"	4	"HEK 293: 4.1;HeLa: 3.9;NTERA-2: 13.5;SH-SY5Y: 4.8;U-251 MG: 4.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042940	Uncertain									"HPA042940: AB_10959525"	"unprognostic (7.88e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.87e-1)"		"unprognostic (8.47e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.48e-8)"	"unprognostic (1.34e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.28e-1)"		0.3	3.9	8.4	0.4	13.5	0.3	0.4	2.8	15.4	5.0	0.9	0.5	0.1	11.7	3.8	0.5	0.4	0.6	0.3	0.3	3.6	9.4	5.0	0.3	0.5	0.3	1.3	8.1	0.3	0.6	0.4	14.2	0.3	4.7	10.6	1.5	3.3	0.4	0.8	0.3	0.4	3.9	2.4	0.8	0.4	0.6	1.6	0.8	0.0	2.1	0.0	0.3	0.3	0.4	0.0	0.0	0.8	0.2	0.3	0.1	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.3	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	8.4	13.5	2.8	15.4	3.6	9.4	1.3	8.1	4.7	0.8
UPK1A	TSPAN21	ENSG00000105668	"Uroplakin 1A"	O00322	19	35666516-35678483	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 20.3;urinary bladder: 80.6"	"Cell line enriched"	"Detected in some"	11	"RT4: 29.2"	"Cancer enriched"	"Detected in many"	41	"urothelial cancer: 148.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA049879	Enhanced									"HPA049879: AB_2680929"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.40e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-9)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.72e-1)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	6.0	0.1	0.1	0.1	0.0	0.4	0.1	12.8	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	20.3	0.0	0.1	0.9	0.1	0.1	6.7	0.1	4.5	0.1	0.1	0.0	0.2	0.1	0.1	0.1	1.1	1.0	80.6	8.6	1.7	0.5	1.8	0.5	1.6	2.0	0.8	0.1	0.9	0.1	0.2	0.3	0.1	0.3	0.2	0.0	0.1	0.4	1.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.7	0.7	0.0	0.3	0.2	0.1	0.1	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.4	0.2	0.0	0.1	0.0	0.0	29.2	0.1	0.3	0.4	0.3	0.5	0.2	0.3	0.9	0.0	1.2	0.1	0.2	0.1	0.4	0.0	0.1	0.1	0.2	1.1	0.5	0.2	0.3	0.4	0.5	0.6	2.0	0.6	0.2	1.7	0.1	0.6	1.8	1.6	0.1	0.5	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
VSTM2A	"MGC33530, VSTM2"	ENSG00000170419	"V-set and transmembrane domain containing 2A"	Q8TAG5	7	54542325-54571080	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 13.7;brain: 51.7;prostate: 13.7"	"Group enriched"	"Detected in some"	6	"Karpas-707: 3.3;SCLC-21H: 10.2;SH-SY5Y: 7.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (1.15e-1)"		"unprognostic (1.02e-1)"		"unprognostic (1.89e-1)"						"unprognostic (1.14e-2)"	"unprognostic (4.66e-1)"	"prognostic favourable (5.34e-4)"	"unprognostic (4.34e-2)"	"unprognostic (6.79e-2)"		"unprognostic (7.15e-2)"	0.7	13.7	18.4	0.7	22.7	0.7	1.1	0.5	51.7	0.7	6.0	1.4	0.0	2.4	0.7	0.7	0.7	0.7	0.9	0.7	9.4	15.5	0.8	0.7	0.8	0.7	4.4	13.6	0.7	1.8	0.7	0.4	0.7	6.7	13.7	5.8	1.1	0.7	0.7	0.8	0.7	1.1	0.8	3.2	0.7	7.2	1.2	3.0	0.0	0.7	0.0	0.7	0.9	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	10.2	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.4	22.7	0.5	51.7	9.4	15.5	4.4	13.6	6.7	3.0
ZNF613	FLJ13590	ENSG00000176024	"Zinc finger protein 613"	Q6PF04	19	51927147-51948759	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 25.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA026833	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA026833: AB_1859377"	"unprognostic (1.10e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.84e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.78e-3)"	"prognostic favourable (1.92e-6)"	4.7	5.3	7.1	3.9	7.4	1.6	9.5	14.2	7.4	5.3	6.5	5.2	1.9	2.8	5.5	5.3	4.7	4.3	3.7	4.3	9.7	4.7	8.7	4.0	4.9	6.3	7.2	4.9	6.5	3.4	7.4	7.0	8.2	8.8	25.4	6.7	5.4	4.5	5.6	3.9	4.5	4.9	5.8	7.5	6.7	4.2	3.5	7.0	9.0	7.3	2.6	5.2	5.8	4.1	10.1	9.6	14.1	11.3	9.5	14.3	7.0	3.1	4.2	6.9	6.9	6.0	6.9	1.7	5.3	8.5	7.1	9.2	1.4	3.7	2.6	2.8	6.6	3.6	6.7	6.6	7.7	0.1	8.6	5.5	3.0	3.9	6.1	0.3	7.9	5.1	7.6	6.7	5.5	7.6	2.5	0.0	7.1	0.6	9.2	4.1	4.9	5.9	5.0	7.3	2.8	6.9	10.8	4.6	4.5	8.5	6.3	5.0	6.6	6.8	4.8	3.1	5.9	2.4	5.6	6.0	0.0	5.1	0.2	0.0	9.3	7.7	7.4	14.1	10.4	7.5	9.3	7.6	11.1	12.1	9.6	10.1	11.2	14.3	7.6	9.5	11.3	4.8	10.0	7.0	7.1	7.4	14.2	7.4	9.7	4.7	7.2	4.9	8.8	7.0
ZNF761	"FLJ16231, FLJ35333, KIAA2033"	ENSG00000160336	"Zinc finger protein 761"		19	53431993-53458261	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"prostate: 33.9"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 31.9"					"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (8.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (4.68e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.13e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.38e-3)"	3.5	3.3	2.9	5.1	4.8	4.2	6.0	3.5	4.3	3.0	3.0	4.4	3.0	2.6	4.1	5.9	2.2	3.7	4.4	1.9	3.3		3.6	1.9	2.9	7.0	4.2	2.4	4.8	7.0	4.7	6.0	12.6	4.2	33.9	3.7	2.3	4.6	5.7	1.8	5.1	3.4	3.1	4.5	4.5	4.1	2.8	5.0	5.2	4.0	2.4	5.3	6.3	10.2	7.8	6.3	6.6	5.4	16.3	9.7	5.1	10.1	5.6	3.8	8.2	11.6	9.9	16.1	6.6	5.5	4.8	7.4	7.7	4.1	9.4	3.8	6.0	7.2	10.3	6.8	7.4	1.3	16.3	9.2	7.7	7.8	6.7	0.5	10.6	9.4	7.2	5.6	9.9	5.0	9.2	5.8	8.0	5.8	10.6	8.6	7.9	8.1	8.2	8.9	10.1	4.3	28.6	5.4	4.4	8.5	10.1	4.1	5.5	8.4	4.6	6.7	5.7	1.2	7.0	7.7	15.5	15.9	0.3	5.0	6.0	6.6	5.4	6.6	6.6	5.4	8.1	7.6	7.4	8.0	5.5	7.8	8.2	8.9	5.0	16.3	5.1	6.3	9.7	5.1										
